Oxycodone

RX_OXYCODONE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N02AJ1[7-9]\|N02AA05\|N02AA5[5-6] 1 out of 7 registries used, show all original rules.	24747
4. Check minimum number of events Min. number of events 3	24747
5. Include endpoints None	24747
6. Filter based on genotype QC (FinnGen only)	21759

Control definitions (FinnGen only)

Control exclude: RX_OPIOIDS

Extra metadata

First used in FinnGen datafreeze: DF10

NAME	RX_OXYCODONE
CONTROL_EXCLUDE	RX_OPIOIDS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N02AJ1[7-9]\|N02AA05\|N02AA5[5-6]
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Oxycodone based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	21759	10762	10997
Unadjusted period prevalence (%)	4.44	3.82	5.04
Median age at first event (years)	69.80	68.89	70.69

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
22423: Matched controls
191625

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

15.4

323.3

311

175

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

5.3

322.6

698

1150

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.5

321.5

1236

3180

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

5.7

320.9

640

976

SPAT1111

SPAT

Planning of analgesia

9.4

320.5

414

381

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

23.9

319.7

255

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

4.1

319.6

956

2063

NK6AN

NOMESCO Finland

Total body bone isotope imaging

4.0

319.5

979

2151

JAH00

NOMESCO Finland

Laparotomy

4.3

318.1

900

1861

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

17.0

315.5

289

147

WX212

NOMESCO Finland

Femoral plexus blockade

5.0

314.8

733

1290

WGA11

NOMESCO Finland

Planning of pain management

21.0

314.4

263

108

TKC20

NOMESCO Finland

Catheterisation of bladder

2.7

314.1

1854

6122

X58

ICD-10 Finland

Exposure to other specified factors

2.2

312.6

2968

12220

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

5.0

311.3

714

1240

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.9

311.1

1011

2318

WPA44, ,

SPAT

19.7

309.3

266

117

394

Kela drug reimbursment

Palbociclib

14.9

308.6

302

176

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

8.4

307.7

533

552

NE1AA

NOMESCO Finland

Pelvis X-ray examination

4.5

307.7

2372

4892

M03BX02

ATC

tizanidine; oral

1.9

307.7

12566

76552

R06.0

ICD-10 Finland

Dyspnoea

2.5

307.7

7071

29939

JN4CD

NOMESCO Finland

Very extensive body CT

5.4

307.7

1531

2572

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.9

307.7

2350

5590

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.1

307.7

1335

2928

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.7

307.7

8138

33373

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

11.7

307.7

633

474

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.8

307.7

1874

4487

M05BX04

ATC

denosumab; parenteral

7.7

307.7

3414

4364

JN6AD

NOMESCO Finland

CT of torso and neck

5.5

307.7

706

1123

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.1

307.7

877

1523

SPAT1255

SPAT

Intravenous administration of medicine

4.5

307.7

2464

5122

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.9

307.7

1829

5697

J01MA02

ATC

ciprofloxacin; systemic

2.4

307.7

10223

49180

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

11.5

307.7

565

431

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.5

307.7

4144

9242

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

33.5

307.7

313

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

5.2

307.7

820

1390

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

5.2

307.7

988

1698

H02AB06

ATC

prednisolone; systemic

3.1

307.7

12989

58729

L01BC59

ATC

trifluridine, combinations; systemic

35.0

307.7

331

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.3

307.7

4780

20405

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

5.5

307.7

1859

3077

R03BB04

ATC

tiotropium bromide; inhalant

2.8

307.7

2774

9297

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

9.7

307.7

803

728

L01BC06

ATC

capecitabine; oral

8.5

307.7

2551

2843

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

19.0

307.7

599

276

116

Kela drug reimbursment

Prostate cancer

2.8

307.7

1872

6005

WX408

NOMESCO Finland

General anesthesy, balanced

3.0

307.7

7149

25702

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.1

307.7

10325

41133

J01FF01

ATC

clindamycin; systemic

2.5

307.7

6846

28522

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

9.0

307.7

1020

1006

A02BC03

ATC

lansoprazole; oral

2.0

307.7

6260

31624

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.5

307.7

1346

3415

GD1AD

NOMESCO Finland

Thorax CT examination

3.6

307.7

2139

5401

C03CA01

ATC

furosemide; systemic

4.0

307.7

10856

36685

S18

ICPC

Laceration/cut

1.9

307.7

10777

62146

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.6

307.7

1478

2877

ZX090

NOMESCO Finland

Other technic of radiotherapy

5.0

307.7

1078

1915

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.9

307.7

1018

1303

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

9.2

307.7

432

407

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.2

307.7

1141

2401

N03AX09

ATC

lamotrigine; oral

4.8

307.7

1185

2221

WF002

NOMESCO Finland

Radical radiotherapy

3.5

307.7

2148

5569

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

307.7

2009

4904

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

8.8

307.7

858

866

R84

ICPC

Malignant neoplasm bronchus/lung

18.8

307.7

289

133

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.3

307.7

2433

6845

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

307.7

3971

15713

L02BX03

ATC

abiraterone; oral

16.6

307.7

575

303

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

6.3

307.7

873

1224

R52.0

ICD-10 Finland

Acute pain

4.9

307.7

866

1554

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

7.7

307.7

1111

1284

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.4

307.7

3131

12121

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.6

307.7

4424

12350

N02AC04

ATC

dextropropoxyphene; oral

6.9

307.7

950

1228

SPAT1167

SPAT

Insertion of urinary catheter

4.6

307.7

1179

2306

R03AC02

ATC

salbutamol; inhalant

1.7

307.7

11048

68632

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

3.2

307.7

2537

7366

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

13.4

307.7

341

220

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

4.3

307.7

4199

9830

TPH04

NOMESCO Finland

Cathetrisation of vein

3.1

307.7

6764

23461

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

5.7

307.7

660

1009

A46

ICD-10 Finland

Erysipelas

2.7

307.7

4239

15451

R52.1

ICD-10 Finland

Chronic intractable pain

50.7

307.7

573

A28

ICPC

Limited function/disability NOS

3.9

307.7

6677

18762

JN4BD

NOMESCO Finland

Extensive body CT

6.0

307.7

5126

9077

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.9

307.7

14638

62270

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

4.5

307.7

2241

4644

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.4

307.7

2055

5582

M03BC01

ATC

orphenadrine (citrate); systemic

2.4

307.7

4379

17764

SPAT1153

SPAT

Removal of sutures

1.8

307.7

7011

37963

A06AH03

ATC

naloxegol; oral

430.8

307.7

2019

130

Kela drug reimbursment

Malignant tumour

14.0

307.7

7598

6757

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.6

307.7

2122

5381

N02AJ06

ATC

codeine and paracetamol; systemic

4.8

307.7

10464

29718

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.0

307.7

1929

4386

A10AB05

ATC

insulin aspart; parenteral

3.2

307.7

2270

6431

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.7

307.7

2570

8875

P01AB01

ATC

metronidazole; oral, rectal

1.9

307.7

8555

46785

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.5

307.7

1989

5180

163

Kela drug reimbursment

Abiraterone and enzalutamide

19.5

307.7

800

362

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

7.3

307.7

695

839

ZXD05

NOMESCO Finland

Urgent procedure

2.5

307.7

7524

32123

N02AA01

ATC

morphine; systemic, rectal

21.3

307.7

1134

477

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.1

307.7

6257

30426

N05AD01

ATC

haloperidol; systemic

4.7

307.7

1190

2255

N05BA06

ATC

lorazepam; systemic, sublingual

5.4

307.7

2178

3747

N02AA05

ATC

oxycodone; systemic

+∞

307.7

22423

7370

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.1

307.7

2553

4684

UJF32

NOMESCO Finland

Coloscopy

2.1

307.7

6466

31181

M54.1

ICD-10 Finland

Radiculopathy

4.6

307.7

981

1903

369

Kela drug reimbursment

Regorafenib

40.4

307.7

243

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

8.9

307.7

499

490

WW500

NOMESCO Finland

Blood transfusion

8.6

307.7

2308

2533

SPAT1262

SPAT

Handing over of treatment supplies

2.4

307.7

4720

19014

L03AA14

ATC

lipegfilgrastim; parenteral

6.2

307.7

732

1042

176

Kela drug reimbursment

Regorafenib

41.4

307.7

249

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

307.7

4241

15323

N05AH04

ATC

quetiapine; oral

2.8

307.7

4145

14538

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.0

307.7

575

628

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

6.4

307.7

762

1043

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

307.7

6298

33266

TQW11

NOMESCO Finland

Vacuum treatment of wound

6.6

307.7

783

1040

L04AX04

ATC

lenalidomide; oral

15.5

307.7

351

196

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

49.4

307.7

364

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

3.5

307.7

1492

3810

A10AE04

ATC

insulin glargine; parenteral

2.5

307.7

2514

9053

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.8

307.7

803

1469

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

9.6

307.7

933

861

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.1

307.7

4146

13228

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

307.7

15006

100474

B01AB04

ATC

dalteparin; parenteral

4.1

307.7

1560

3443

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

3.9

307.7

1589

3709

M48.0

ICD-10 Finland

Spinal stenosis

4.7

307.7

3736

7816

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.8

307.7

3157

10508

ZX070

NOMESCO Finland

Intensity modified radiotherapy

5.3

307.7

710

1169

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

8.7

307.7

754

763

C20

ICD-10 Finland

Malignant neoplasm of rectum

9.1

307.7

518

497

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.5

307.7

2702

10099

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.8

307.7

2058

4991

L03

ICPC

Low back symptom/complaint

2.1

307.7

5721

27279

M04AA01

ATC

allopurinol; systemic

2.4

307.7

3422

13514

ZZA00

NOMESCO Finland

Split skin graft

4.5

307.7

909

1774

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

24.6

307.7

816

294

ZXA00

NOMESCO Finland

Right side

2.1

307.7

6016

28129

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.5

307.7

6005

18055

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.8

307.7

6839

19854

N05CD07

ATC

temazepam; oral

2.7

307.7

3066

10531

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.8

307.7

1021

1896

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.2

307.7

750

1058

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

3.5

307.7

3310

9151

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.5

307.7

1341

3408

A04AD12

ATC

aprepitant; systemic

7.1

307.7

932

1160

A41.9

ICD-10 Finland

Sepsis, unspecified

4.5

307.7

1310

2615

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

307.7

3754

16262

B01AB05

ATC

enoxaparin; parenteral

3.8

307.7

9897

32909

M54.5

ICD-10 Finland

Low back pain

2.7

307.7

8291

34575

SPAT1211

SPAT

Application of soft bandage

2.7

307.7

2115

7093

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.3

307.7

4989

15128

M01AH01

ATC

celecoxib; oral

2.6

307.7

4141

15592

M54.3

ICD-10 Finland

Sciatica

3.4

307.7

1306

3385

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

7.8

307.7

940

1065

N06AA09

ATC

amitriptyline; systemic

4.7

307.7

2828

5697

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

307.7

6655

33894

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.7

307.7

1937

6401

N06AX11

ATC

mirtazapine; oral

3.0

307.7

9154

35660

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

6.1

307.7

753

1078

N03AX16

ATC

[U] pregabalin

9.6

307.7

9499

13607

Z2446

NOMESCO Finland

Social worker

3.5

307.7

1574

4011

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.8

307.7

9538

54885

WZC30

NOMESCO Finland

Teaching

3.6

307.7

5940

17501

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

8.6

307.7

1388

1459

J01MA14

ATC

moxifloxacin; systemic

3.3

307.7

2628

7467

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

7.3

307.7

614

733

SPAT1125

SPAT

Stoma care and guidance

6.0

307.7

701

1021

R52.9

ICD-10 Finland

Pain, unspecified

2.7

307.7

2484

8373

N02BF02

ATC

pregabalin; oral

8.7

307.7

2623

2885

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.1

307.7

1711

3812

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.3

307.7

1798

4939

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.5

307.7

2924

7789

XX3DW

NOMESCO Finland

Time consuming IT work

4.3

307.7

4421

10380

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

13.7

307.7

916

595

WX402

NOMESCO Finland

General anaesthesia

2.0

307.7

4832

23321

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.7

307.7

1536

3740

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

15.4

307.7

787

452

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.4

307.7

1277

2589

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

4.2

307.7

1142

2411

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

8.6

307.7

568

580

R4110

NOMESCO Finland

Physiotherapy

2.2

307.7

6531

29605

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

34.3

307.7

274

J01MA12

ATC

levofloxacin; systemic

3.7

307.7

6435

18581

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

307.7

7935

36815

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.6

307.7

1257

3110

WF004

NOMESCO Finland

Palliative radiotherapy

21.3

307.7

2030

890

K83.1

ICD-10 Finland

Obstruction of bile duct

8.6

307.7

718

736

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.0

307.7

2663

8177

R50.9

ICD-10 Finland

Fever, unspecified

3.9

307.7

5280

14150

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

6.1

307.7

986

1434

SPAT1254

SPAT

Administration of medicine

3.7

307.7

4961

13590

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

5.3

307.7

3124

5652

R5110, ,

SPAT

3.1

307.7

2454

7339

A02BC02

ATC

pantoprazole; systemic

4.7

307.7

18519

96073

D70.82

ICD-10 Finland

Drug-induced neutropenia

7.3

307.7

736

884

M54.4

ICD-10 Finland

Lumbago with sciatica

3.3

307.7

4217

12616

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

40.2

307.7

443

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

7.0

307.7

1008

1284

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

36.8

307.7

7180

2423

N03AX12

ATC

[U] gabapentin; oral

8.7

307.7

6380

8355

M01AB05

ATC

diclofenac; systemic, rectal

1.7

307.7

13497

88834

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

4.6

307.7

1602

3149

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

33.3

307.7

315

WF049

NOMESCO Finland

Radiotherapy of metastasis

25.4

307.7

3897

1576

N02AJ13

ATC

tramadol and paracetamol; systemic

12.6

307.7

509

353

K59.09

ICD-10 Finland

Constipation, unspecified

3.2

307.7

2021

5794

WX892

NOMESCO Finland

Monitored bed care

3.1

307.7

2215

6476

JN4AD

NOMESCO Finland

Body CT examination

5.8

307.7

6026

11396

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

11.0

307.7

688

552

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

307.7

4498

18744

N02AA03

ATC

hydromorphone; systemic, rectal

166.8

307.7

289

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

3.7

307.7

1182

2839

R53

ICD-10 Finland

Malaise and fatigue

2.1

307.7

5740

27270

N03AE01

ATC

clonazepam; systemic

3.8

307.7

1515

3542

A04AA55

ATC

palonosetron, combinations; systemic

6.7

307.7

1715

2354

J01DB01

ATC

cefalexin; oral

2.7

307.7

18805

125368

R33

ICD-10 Finland

Retention of urine

2.7

307.7

2439

8163

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

9.5

307.7

1480

1420

AA1AD

NOMESCO Finland

CT of head and brain

2.5

307.7

8113

35487

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.1

307.7

3373

8026

N05CF01

ATC

zopiclone; oral

3.2

307.7

9442

35082

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.4

307.7

2558

9624

1501

Kela drug reimbursment

Palbociclib

15.1

307.7

327

188

A04

ICPC

Weakness/tiredness general

2.3

307.7

3783

15518

SPAT1231

SPAT

Assessment of adjustments needed in living environment

5.8

307.7

680

1036

S97

ICPC

Chronic ulcer skin

4.6

307.7

2308

4667

ZXA05

NOMESCO Finland

Left side

2.1

307.7

5543

26120

JN3AD

NOMESCO Finland

Abdominal CT examination

4.0

307.7

4735

12162

B03XA02

ATC

darbepoetin alfa; parenteral

6.3

307.7

866

1217

M01AH02

ATC

rofecoxib; oral

2.4

307.7

2826

10732

NF1AA

NOMESCO Finland

Hip X-ray examination

4.2

307.7

2935

6686

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

15.9

307.7

3919

2513

SPAT1229

SPAT

Assessment of need for aid

4.7

307.7

2855

5790

H02AB02

ATC

dexamethasone; systemic

10.6

307.7

8047

9653

R60.0

ICD-10 Finland

Localized oedema

2.7

307.7

3449

12134

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

6.4

307.7

721

986

NG2AA

NOMESCO Finland

Patella X-ray examination

5.1

307.7

731

1247

A41.8

ICD-10 Finland

Other specified sepsis

5.4

307.7

715

1167

I50.9

ICD-10 Finland

Heart failure, unspecified

2.3

307.7

3903

15772

JDB10

NOMESCO Finland

Percutaneous gastrostomy

7.0

307.7

565

702

A01

ICPC

Pain general/multiple sites

4.3

307.7

3207

7122

N02BE01

ATC

paracetamol; systemic, rectal

5.7

307.7

21113

141771

TPX10

NOMESCO Finland

Implantation of vascular injection port

11.1

307.7

1863

1558

B01AB10

ATC

tinzaparin; parenteral

4.3

307.7

4115

9439

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.4

307.7

1426

2401

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

9058

49851

A02BC01

ATC

omeprazole; systemic

2.1

307.7

6239

29608

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

307.7

4355

16960

C03DA01

ATC

spironolactone; oral

2.3

307.7

3130

12866

N02AX02

ATC

tramadol; systemic, rectal

8.2

307.7

13640

30405

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

4.7

307.7

918

1742

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

13.1

307.7

692

466

ZXE20

NOMESCO Finland

More than three and less than five hours

3.0

307.7

3643

11676

L03AA02

ATC

filgrastim; parenteral

8.3

307.7

1694

1877

C90.0

ICD-10 Finland

Multiple myeloma

8.6

307.7

513

523

WZC00

NOMESCO Finland

Treatment plan or consultation

3.4

307.7

11340

44042

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.2

307.7

1897

5353

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

4.0

307.7

3633

8785

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

5.2

307.7

782

1335

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.7

307.7

3262

8357

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

13.1

307.7

1872

1327

R06AE07

ATC

cetirizine; oral

1.9

307.7

9074

51178

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.6

307.7

1007

1958

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

5.0

307.7

924

1637

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

307.7

8060

40306

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

17.4

307.7

3669

2126

N06AX16

ATC

venlafaxine; oral

3.6

307.7

3666

9789

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

6.4

307.7

3462

5338

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

6.8

307.7

545

696

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

12.0

307.7

841

618

A49.9

ICD-10 Finland

Bacterial infection, unspecified

6.2

307.7

5760

10103

Z3231

NOMESCO Finland

Registered nurse

2.1

307.7

6373

30562

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.1

307.7

1245

2703

ZX120

NOMESCO Finland

Intravenous

4.7

307.7

3714

7698

Z51.5

ICD-10 Finland

Palliative care

21.6

307.7

8901

5674

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

10.1

307.7

485

417

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

9.7

307.7

853

782

A07AA02

ATC

nystatin; oral

3.1

307.7

1581

4508

A79

ICPC

Malignancy NOS

11.9

307.7

1116

842

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.3

307.7

1075

2212

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

6.8

307.7

629

808

UKC02

NOMESCO Finland

Cystoscopy

2.2

307.7

4305

18421

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.2

307.7

1416

3009

A04AA02

ATC

granisetron; systemic, transdermal

9.5

307.7

4240

4612

Z3226

NOMESCO Finland

Physiotherapist

2.4

307.7

3949

15597

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

13.1

307.7

339

224

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.2

307.7

9561

47754

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.3

307.7

935

1927

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

307.7

7920

42934

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

307.7

6728

30480

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

8.3

307.7

643

678

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.4

307.7

2566

7001

R52.2

ICD-10 Finland

Other chronic pain

9.7

307.7

1570

1478

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.8

307.7

1199

1575

C07AB07

ATC

bisoprolol; oral

1.9

307.7

11646

70316

SPAT1109

SPAT

Analgesia with portable analgesic pump

33.1

307.7

519

137

A02BC05

ATC

esomeprazole; systemic

2.1

307.7

9302

48381

N05BA01

ATC

diazepam; systemic, rectal

3.0

307.7

3352

10767

N06AA10

ATC

nortriptyline; systemic

7.8

307.7

625

700

WX002

NOMESCO Finland

Sedation and analgesia

2.6

307.7

4859

18677

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.6

307.7

998

1929

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

114.9

307.7

5028

481

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.0

307.7

8251

31257

A03FA01

ATC

metoclopramide; systemic, rectal

9.8

307.7

12029

20171

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.8

307.7

1221

2863

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.6

307.7

2370

4817

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

21.6

307.7

2058

892

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

24.3

307.7

289

103

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.3

307.7

893

1498

SPAT1245

SPAT

Provision of support and information to patient’s family members

4.0

307.7

1528

3425

128

Kela drug reimbursment

Cancers of female genital organs

6.2

307.7

692

987

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.3

307.7

975

1986

UJK02

NOMESCO Finland

ERCP

4.9

307.7

1010

1832

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

21.8

307.7

3609

1668

L01CA04

ATC

vinorelbine; systemic

17.5

307.7

602

302

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.4

307.7

4027

16126

A29

ICPC

General symptom/complaint other

2.2

307.7

3360

14280

192

Kela drug reimbursment

Fulvestrant

23.3

307.7

368

137

L86

ICPC

Back syndrome with radiating pain

3.9

307.7

1454

3355

SPAT1234

SPAT

Support of social functional capacity

3.4

307.7

1657

4382

L02BA03

ATC

fulvestrant; parenteral

21.7

307.7

451

181

WX302

NOMESCO Finland

Thoracal epidural anesthesy

5.0

307.7

2205

4117

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

11.3

307.7

552

426

E0000UV, ,

ATC

2.0

307.7

9601

51924

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.7

307.7

2086

7036

L03AA13

ATC

pegfilgrastim; parenteral

6.2

307.7

2161

3245

R51.80

ICD-10 Finland

Headache

2.3

307.7

2976

11850

352

Kela drug reimbursment

Abiraterone and enzalutamide

16.0

307.7

546

298

A06AD11

ATC

lactulose; oral

6.2

307.7

6773

12569

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.1

307.7

11565

64786

L28

ICPC

Limited function/disability (L)

3.7

307.7

6405

18786

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

41.2

307.7

389

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

10.6

307.7

548

451

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

28.0

307.7

256

D64.9

ICD-10 Finland

Anaemia, unspecified

2.8

307.7

3321

11347

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

4.6

307.7

10847

32436

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.5

307.7

3246

11963

H02AB07

ATC

prednisone; oral

2.5

307.7

3270

12308

ZXE00

NOMESCO Finland

One hour or less

1.8

307.7

8021

45160

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.8

307.7

5364

14649

153

Kela drug reimbursment

Lenalidomid

15.5

307.7

368

206

SPAT1216

SPAT

Assessment of functional ability

2.9

307.7

4721

16067

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

13.7

307.7

1352

894

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

7.9

307.7

537

594

N05BA04

ATC

oxazepam; oral

3.4

307.7

7809

25828

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

8.7

307.7

481

482

SPAT1263

SPAT

Sampling

2.0

307.7

9410

51381

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

11.2

307.7

1237

990

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.5

307.7

1391

3596

WX320

NOMESCO Finland

Spinalanesthesy

2.0

307.7

5172

24680

R11

ICD-10 Finland

Nausea and vomiting

3.9

307.7

2701

6578

A04AA01

ATC

ondansetron; systemic, rectal

12.3

307.7

5881

5384

N06AB04

ATC

citalopram; systemic

2.1

307.7

4469

20631

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

6.4

307.7

661

909

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.5

307.7

4363

12308

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

6.9

307.7

1515

2000

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.5

307.7

8834

39477

ZX112

NOMESCO Finland

Subcutaneous

5.7

307.7

837

1294

NF3AA

NOMESCO Finland

Femur X-ray examination

7.1

307.7

832

1038

L02BB04

ATC

enzalutamide; oral

14.4

307.7

712

436

M03BX01

ATC

baclofen; systemic

6.5

307.7

591

794

N05CF02

ATC

zolpidem; oral

2.3

307.7

3677

15148

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.2

307.7

2916

8457

N02BF01

ATC

gabapentin; oral

5.6

307.7

3201

5580

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

307.7

6552

33625

R18

ICD-10 Finland

Ascites

6.0

307.7

840

1234

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

23.6

307.7

791

296

SPAT1301

SPAT

No procedures

2.1

307.7

7512

37444

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.3

307.7

1520

4149

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

8.9

307.7

531

521

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

7.6

307.7

736

848

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

12.1

307.7

666

485

TPH07

NOMESCO Finland

Cathetrisation of artery

3.1

307.7

3516

10854

N07BC02

ATC

methadone; systemic

614.4

307.7

424

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

307.7

4089

16681

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.4

307.7

3525

14010

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

5.3

307.7

897

1485

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.5

307.7

2784

5891

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.8

307.7

818

1485

A02BA02

ATC

ranitidine; systemic

2.1

307.7

4311

19780

N06AX21

ATC

duloxetine; oral

6.1

307.7

4031

6638

R4190

NOMESCO Finland

Nutritional therapy

6.4

307.7

1453

2047

J94.8

ICD-10 Finland

Other specified pleural conditions

5.4

307.5

653

1057

JAH01

NOMESCO Finland

Laparoscopy

3.5

307.1

1167

2978

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

6.9

305.9

510

645

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

304.3

2104

7516

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.2

303.1

1313

3640

J01EA01

ATC

trimethoprim; systemic

1.9

302.5

5385

27796

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

5.1

299.7

686

1189

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

299.6

5564

29091

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.7

299.1

601

923

R02

ICPC

Shortness of breath/dyspnoea

2.2

298.6

3046

12896

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

10.3

298.5

363

306

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.6

298.5

1086

2692

NHQ40

NOMESCO Finland

Amputation of toe

6.0

298.1

564

816

M01AX17

ATC

nimesulide; oral

1.9

297.8

4973

25130

D76

ICPC

Malignant neoplasm pancreas

26.1

297.1

230

329

Kela drug reimbursment

Lenalidomide

15.4

295.2

284

160

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

294.2

3929

18399

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

294.1

3057

13033

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

13.7

292.0

298

188

WPA43, ,

SPAT

40.8

290.4

199

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

288.4

7727

44869

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.1

287.0

1308

3736

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

5.6

286.3

590

928

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

286.2

5748

30712

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

13.2

285.4

298

196

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

284.3

4067

19482

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

5.2

284.3

623

1038

XF600

NOMESCO Finland

Bloodpressure measurement

2.8

283.8

1562

4963

SPAT1172

SPAT

Guidance concerning hydration

4.3

283.4

800

1650

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

5.5

282.3

585

925

WPB10

NOMESCO Finland

Making a convalescent care decision

13.9

282.3

286

178

L02BB03

ATC

bicalutamide; oral

3.9

282.0

893

2008

M01AE02

ATC

naproxen; oral, rectal

1.7

280.6

10823

69044

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

279.5

3993

19108

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

5.9

278.0

538

796

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

277.4

1523

4831

N30.0

ICD-10 Finland

Acute cystitis

2.0

277.1

3629

16841

H02AB09

ATC

hydrocortisone; systemic

4.7

276.4

682

1261

N04BC05

ATC

pramipexole; oral

2.7

275.9

1692

5686

XW000

NOMESCO Finland

Bone marrow biopsy

3.2

274.8

1195

3317

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

5.9

274.6

529

779

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.0

274.4

1313

3857

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.2

274.3

778

1610

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.4

274.1

586

954

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.3

273.2

763

1560

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

3.5

272.9

1002

2497

ZX080

NOMESCO Finland

Image guided radiotherapy

4.5

272.6

720

1408

WX308

NOMESCO Finland

Sacral anesthesy

47.2

272.3

181

L02AE02

ATC

leuprorelin; implant, parenteral

2.9

271.4

1427

4420

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.6

270.7

686

1297

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

4.3

270.0

761

1567

B01AA03

ATC

warfarin; systemic

1.9

269.6

4388

21901

M01AX05

ATC

glucosamine; oral

1.9

269.0

4008

19429

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

268.3

2201

8484

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

7.2

267.9

429

518

D77

ICPC

Malignant digestive neopl other/NOS

13.4

267.9

277

179

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.7

267.7

914

2167

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

13.0

266.6

280

186

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

8.2

266.6

381

401

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

266.3

4973

25905

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

8.7

265.7

365

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.3

264.8

1104

2985

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.7

264.7

667

1255

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

8.6

264.0

365

368

L01CB01

ATC

etoposide; systemic

12.3

263.6

286

201

WX882

NOMESCO Finland

High dependency care

4.0

263.2

813

1794

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.3

263.0

1087

2923

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.3

262.3

734

1503

SPAT1252

SPAT

Overall medication plan or its review

2.5

262.1

1770

6234

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

8.2

261.5

374

394

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.7

261.4

1503

4882

WF003

NOMESCO Finland

Adjuvant radiotherapy

3.3

260.7

1075

2886

N06AB10

ATC

escitalopram; oral

2.0

258.8

3672

17484

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

16.3

257.1

240

127

M43.1

ICD-10 Finland

Spondylolisthesis

3.8

256.6

846

1957

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

5.3

255.8

550

900

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

255.6

5570

30318

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

255.1

1944

7243

OAB43, ,

SPAT

0.4

254.9

1266

26296

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.7

254.7

1491

4887

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.8

254.3

427

544

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

25.2

254.1

199

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.4

254.0

2069

7942

J01AA02

ATC

doxycycline; systemic

1.7

253.7

16500

118781

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

7.9

253.5

375

412

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

5.4

253.4

537

867

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

15.6

253.0

241

133

M01AC06

ATC

meloxicam; systemic, rectal

1.7

252.2

7006

40743

M01AH05

ATC

etoricoxib; oral

1.6

252.0

11875

78786

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

250.9

5517

30081

NFQ20

NOMESCO Finland

Amputation of femur

8.9

249.4

335

325

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.6

248.5

1569

5343

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

13.7

248.4

253

159

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

6.4

248.0

441

598

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

9.0

247.8

332

321

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.7

246.5

1485

4938

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

246.4

2521

10633

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.8

245.6

1321

4138

S22.3

ICD-10 Finland

Fracture of rib

2.6

245.2

1595

5511

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

244.9

2995

13513

SPAT1260

SPAT

Consultation of another employee

1.9

244.5

3813

18704

197

Kela drug reimbursment

Sunitinib

14.9

243.1

237

137

L02BX02

ATC

degarelix; parenteral

5.8

242.1

477

718

M02AA07

ATC

piroxicam; topical

1.7

241.9

7257

42948

C01DA14

ATC

isosorbide mononitrate; oral

1.9

241.3

3640

17653

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

12.6

239.8

256

175

1523, ,

Kela drug reimbursment

8.8

239.5

326

322

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.9

238.8

1212

3676

3054, ,

Kela drug reimbursment

8.8

238.8

325

321

A07AA09

ATC

vancomycin; oral

5.8

238.4

470

708

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

28.5

237.8

179

ZX095

NOMESCO Finland

Combined chemoradiotherapy

8.7

237.8

326

325

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.7

236.9

800

1881

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

236.9

4798

25484

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.6

236.8

839

2039

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

14.4

236.5

235

141

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

236.1

4751

25182

M01AB55

ATC

diclofenac, combinations; oral

2.7

236.1

1386

4545

NB6AA

NOMESCO Finland

Humerus X-ray examination

4.5

235.9

624

1221

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.8

235.9

765

1748

TAC99

NOMESCO Finland

Other blockade for chronic pain

12.7

234.9

250

170

M89.0

ICD-10 Finland

Algoneurodystrophy

11.6

234.7

264

197

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

4.7

233.7

583

1087

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

10.8

233.3

275

221

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.8

232.9

763

1756

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

11.1

232.5

268

208

WPA13

NOMESCO Finland

Palliative consultation

11.7

232.0

259

191

B03BA03

ATC

hydroxocobalamin; parenteral

2.6

231.8

1440

4859

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.0

231.5

1093

3180

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

231.3

7888

48077

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

230.9

786

1858

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.9

230.5

381

477

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

7.6

229.5

350

399

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.2

229.0

982

2698

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.6

228.7

814

1984

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

228.0

7439

44808

B01AF01

ATC

rivaroxaban; oral

2.0

228.0

2738

12250

NA2AD

NOMESCO Finland

Thoracic spine CT examination

10.7

227.7

269

217

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.6

225.3

1479

5127

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

224.4

1612

5833

J01FA06

ATC

roxithromycin; oral

1.6

224.2

7811

47762

L01XE33

ATC

[U] palbociclib

17.0

223.9

205

104

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

3.8

223.8

734

1690

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

4.8

223.6

539

976

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

223.6

1392

4700

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.2

223.2

945

2576

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

223.1

5593

31452

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

5.2

222.5

489

816

SPAT1240

SPAT

Therapeutic discussion

2.3

222.4

1821

6990

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.9

221.9

1130

3431

J01DA01

ATC

[U] cefalexin

1.6

221.3

12398

84535

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

4.5

221.0

581

1131

WX213

NOMESCO Finland

Lower leg blockade

8.9

220.8

298

291

WX610

NOMESCO Finland

Patient controlled analgesia

10.0

220.0

273

237

1XC07, ,

NOMESCO Finland

24.8

219.8

173

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.2

219.5

950

2624

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

5.0

219.3

502

869

R13

ICD-10 Finland

Dysphagia

2.4

219.3

1642

6055

N05BA12

ATC

alprazolam; oral

2.2

219.1

2055

8351

J01CA04

ATC

amoxicillin; systemic

1.7

219.0

16678

122090

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.9

219.0

703

1594

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.8

218.3

709

1621

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.3

218.3

1923

7614

W19

ICD-10 Finland

Unspecified fall

2.2

218.2

2155

8941

TAB20

NOMESCO Finland

Epidural puncture

11.1

217.6

251

195

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

217.3

6056

34971

M79.7

ICD-10 Finland

Fibromyalgia

4.1

217.2

634

1340

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

217.0

2578

11476

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

216.3

4091

21224

G04CA02

ATC

tamsulosin; oral

1.7

216.3

5661

32155

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.7

215.9

728

1709

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

14.5

215.0

213

127

N05AH03

ATC

olanzapine; systemic

2.6

215.0

1390

4780

M05BA04

ATC

alendronic acid; oral

2.2

213.4

1953

7853

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

4.4

213.4

576

1145

M54.8

ICD-10 Finland

Other dorsalgia

3.1

212.6

948

2665

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.4

212.6

811

2069

M54

ICD-10 Finland

Dorsalgia

2.2

212.1

2130

8892

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

211.9

4962

27333

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

5.4

211.8

452

734

ZYC01

NOMESCO Finland

Remote contact by phone

2.5

211.7

1452

5137

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

6.9

211.5

352

444

C08CA01

ATC

amlodipine; oral

1.6

211.1

8706

55171

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.2

211.0

896

2446

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.5

210.9

778

1941

SPAT1104

SPAT

Monitoring of emergency patient

2.5

210.9

1487

5330

Y77

ICPC

Malignant neoplasm prostate

3.1

210.4

979

2822

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

26.3

209.8

162

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

209.5

3890

20048

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

209.1

1404

4916

H02AB04

ATC

methylprednisolone; systemic

1.9

207.8

2869

13452

R31

ICD-10 Finland

Unspecified haematuria

2.0

207.3

2556

11520

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.7

207.1

695

1626

N06AA12

ATC

doxepin; systemic

2.8

206.3

1127

3553

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

7.3

206.0

324

383

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.2

205.9

867

2354

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.1

205.8

610

1304

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

11.8

205.8

228

166

K83.0

ICD-10 Finland

Cholangitis

5.0

205.6

475

829

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

5.4

205.3

436

705

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

10.3

205.2

248

207

U04

ICPC

Incontinence urine

2.5

204.5

1404

4967

XX1XW

NOMESCO Finland

Extensive written report from radiologist

4.2

204.0

590

1238

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.6

203.2

1335

4624

M54.6

ICD-10 Finland

Pain in thoracic spine

2.5

202.8

1372

4820

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

202.8

1308

4490

SPAT1088

SPAT

Blood transfusion

9.8

202.4

253

222

A06AH05

ATC

naldemedine; oral

608.6

202.0

212

J04AB02

ATC

rifampicin; systemic

6.4

201.7

359

487

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.1

200.9

926

2654

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

200.4

1316

4557

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

16.3

200.2

187

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

11.7

200.0

223

164

C56

ICD-10 Finland

Malignant neoplasm of ovary

8.7

199.9

274

273

NF1DA

NOMESCO Finland

X-ray of hips

4.7

199.6

495

918

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

7.3

199.5

315

374

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

26.9

199.5

153

SPAT1276

SPAT

Outlining of treatment with patient or their family members

3.9

196.6

630

1426

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

7.0

196.5

322

399

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.5

196.5

719

1784

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.2

196.3

859

2387

WPA44

NOMESCO Finland

Nursing home for palliative care

19.8

196.2

168

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

196.2

1584

6032

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.5

195.9

1306

4554

L13

ICPC

Hip symptom/complaint

1.8

195.8

3692

19075

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

4.4

195.7

524

1035

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

195.7

4250

22866

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

5.6

195.5

394

606

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

16.0

195.5

184

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

8.8

195.5

264

258

A10AC01

ATC

insulin (human); parenteral

2.3

195.3

1663

6479

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.2

195.3

857

2385

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.5

195.2

1305

4556

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.9

195.0

1008

3083

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

22.4

194.9

159

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.7

194.3

1142

3740

E66.8

ICD-10 Finland

Other obesity

3.0

193.5

953

2837

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.0

193.3

589

1285

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

5.4

193.0

411

666

N07BA03

ATC

varenicline; oral

2.9

192.9

960

2874

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

6.9

192.5

320

403

J96.1

ICD-10 Finland

Chronic respiratory failure

3.7

192.1

644

1505

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.1

191.6

571

1225

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

191.5

4363

23768

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.5

191.1

1350

4837

L01AX03

ATC

temozolomide; systemic

7.3

191.1

302

359

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.6

190.8

1216

4147

Z93.3

ICD-10 Finland

Colostomy status

6.7

189.6

323

418

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

8.4

189.6

265

271

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

188.7

1558

5988

K92.1

ICD-10 Finland

Melaena

2.5

187.9

1316

4696

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

11.5

187.2

211

158

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

13.0

186.8

196

130

N06AX03

ATC

mianserin; oral

2.8

186.6

1043

3326

L01XE21

ATC

[U] regorafenib

71.2

186.6

116

C45.0

ICD-10 Finland

Mesothelioma of pleura

16.3

186.4

174

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

6.8

186.4

312

396

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

186.0

2684

12740

PE1AT

NOMESCO Finland

Femoral artery PTA

5.7

186.0

372

568

XX7FT

NOMESCO Finland

Radioyttrium therapy with connected antibody

52.0

185.3

121

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

184.9

2679

12732

M01AB51

ATC

indometacin, combinations; oral, rectal

4.1

184.6

534

1120

393

Kela drug reimbursment

Pomalidomide

36.0

184.1

130

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.0

183.6

2459

11380

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.8

183.5

977

3035

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.8

183.2

601

1383

J01CF05

ATC

flucloxacillin; systemic

2.4

183.1

1448

5459

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

183.0

1892

7968

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

5.5

182.7

376

590

G56.4

ICD-10 Finland

Causalgia

16.8

182.7

168

3012

Kela drug reimbursment

Cabozantinib

18.5

182.6

161

D07AA02

ATC

hydrocortisone; topical

1.9

182.4

2588

12210

OAA67, ,

SPAT

0.3

181.8

600

15373

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.0

181.8

871

2551

L04AX06

ATC

pomalidomide; oral

37.6

181.8

127

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.7

181.8

447

823

J01XX08

ATC

linezolid; systemic

8.8

181.6

245

239

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

4.1

180.6

526

1109

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.9

180.6

896

2677

1502

Kela drug reimbursment

Cabozantinib

18.1

180.0

160

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

179.5

3145

15860

L01EF01

ATC

palbociclib; oral

13.4

179.3

185

119

N06AB03

ATC

fluoxetine; oral

2.0

179.0

2244

10145

1507

Kela drug reimbursment

Pomalidomide

37.0

178.2

125

T90

ICPC

Diabetes non-insulin dependent

1.6

178.1

5351

31210

D75

ICPC

Malignant neoplasm colon/rectum

6.1

177.9

333

476

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.9

177.4

2442

11398

A08

ICPC

Swelling

2.4

177.3

1295

4709

L29

ICPC

Musculoskeletal sympt/complt other

2.1

177.1

1808

7574

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

176.9

18477

141165

V03AE01

ATC

polystyrene sulfonate; oral

4.9

176.7

414

731

E86

ICD-10 Finland

Volume depletion

3.4

176.1

694

1806

TK800

NOMESCO Finland

Hemodialysis

3.8

175.4

582

1350

TGC00

NOMESCO Finland

Bronchial lavation

3.3

175.4

694

1811

E87.5

ICD-10 Finland

Hyperkalaemia

4.0

175.3

540

1187

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

7.6

175.0

266

302

TJA10

NOMESCO Finland

Laparocentesis

14.7

175.0

172

101

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.0

174.8

400

692

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.6

174.7

441

830

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

4.4

174.7

467

921

I50.0

ICD-10 Finland

Congestive heart failure

2.1

174.4

1802

7583

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.1

174.3

1969

8569

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.0

174.3

2217

10069

159

Kela drug reimbursment

Pazopanib

19.5

174.3

150

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

3.4

174.1

681

1764

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.0

173.8

846

2500

N03AF01

ATC

carbamazepine; oral, rectal

2.6

173.7

1076

3615

M25.5

ICD-10 Finland

Pain in joint

1.6

173.7

5651

33559

B01AC04

ATC

clopidogrel; oral

1.7

172.7

3655

19447

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.7

172.3

986

3181

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.6

172.0

440

837

L76

ICPC

Fracture: other

3.1

171.9

758

2114

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

5.9

171.9

329

481

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

40.5

171.8

118

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

171.8

1429

5503

J02AC01

ATC

fluconazole; systemic

1.5

171.7

6955

43375

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.3

171.2

466

932

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.0

171.1

2006

8846

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

9.2

171.1

225

212

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

5.4

170.7

360

578

C61

ICD-10 Finland

Malignant neoplasm of prostate

1.9

170.6

2429

11459

XG410

NOMESCO Finland

Flow-volume spirometry

2.9

170.2

889

2732

WPA11

NOMESCO Finland

Developing a plan for palliative care

16.0

170.1

160

E87.6

ICD-10 Finland

Hypokalaemia

2.9

170.0

868

2634

WVA20

NOMESCO Finland

Medicine administration

3.2

169.9

729

2000

ZX121

NOMESCO Finland

Central venous catheter

12.3

169.8

184

129

JLC30

NOMESCO Finland

Pancreatoduodenectomy

7.7

169.7

256

288

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

16.8

169.5

156

XKD00

NOMESCO Finland

Uroflowmetry

1.7

169.5

3648

19492

N06AB06

ATC

sertraline; oral

2.0

169.0

1961

8614

S06.0

ICD-10 Finland

Concussion

2.0

168.9

2100

9457

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

168.7

1562

6290

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

5.4

168.7

355

569

SPAT1304

SPAT

Counselling and guidance related to ageing

2.1

167.7

1769

7499

ZY010

NOMESCO Finland

Hospital outpatient

2.8

167.7

933

2966

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

167.5

3135

16096

SPAT1290

SPAT

Preparation of deceased person

23.8

166.6

133

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.9

166.5

519

1151

L75

ICPC

Fracture: femur

4.9

166.4

393

699

J01CA08

ATC

pivmecillinam; oral

1.5

166.3

7222

45646

5BA08, ,

NOMESCO Finland

11.0

165.9

192

150

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

6.0

165.8

315

457

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

7.0

165.6

269

330

318

Kela drug reimbursment

Teriparatide

12.3

165.6

179

125

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

8.4

165.6

232

238

R10.0

ICD-10 Finland

Acute abdomen

3.1

165.4

726

2019

M09AX01

ATC

hyaluronic acid; parenteral

2.7

165.2

941

3028

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.6

165.1

577

1387

1CD01, ,

NOMESCO Finland

18.6

165.0

145

S72.0

ICD-10 Finland

Fracture of neck of femur

2.7

164.8

988

3264

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

4.5

164.4

430

833

-50

ICPC

Medication/prescr/renewal

2.8

164.4

880

2740

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

164.3

4745

27330

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.9

163.6

830

2509

N05AA02

ATC

levomepromazine; systemic

2.8

163.5

884

2767

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

9.4

163.3

211

194

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.7

162.2

275

354

NGQ20

NOMESCO Finland

Amputation of lower leg

8.5

162.1

225

228

ZZH31

NOMESCO Finland

Bone allograft, small pieces

8.3

162.0

230

240

SPAT1310

SPAT

Counselling related to known health issue

1.5

161.6

6158

37788

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

5.8

161.6

314

466

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

12.5

161.4

173

119

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.6

161.4

1034

3530

E000001, ,

ATC

1.7

161.4

3730

20288

TPX15

NOMESCO Finland

Removal of vascular injection port

9.0

161.4

214

204

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.1

161.2

716

2005

1CD02, ,

NOMESCO Finland

6.1

161.0

298

421

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

160.9

1703

7224

L02BG06

ATC

exemestane; oral

4.1

160.8

479

1027

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

1.9

160.1

2310

10932

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

13.4

159.3

164

105

WF001

NOMESCO Finland

Preoperative radiotherapy

5.1

159.2

354

597

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

7.0

159.1

258

316

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.9

158.9

496

1101

WYA20

NOMESCO Finland

Home visit

3.8

158.7

521

1199

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

5.6

158.5

319

490

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

158.4

1393

5488

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

5.5

157.9

323

504

ZZH40

NOMESCO Finland

Substitute of bone

8.4

157.7

222

229

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

23.2

157.7

127

M05BA02

ATC

clodronic acid; systemic

11.3

157.4

179

136

S70.0

ICD-10 Finland

Contusion of hip

2.8

156.9

855

2687

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

8.5

156.8

217

219

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

6.0

156.8

294

421

C10AA01

ATC

simvastatin; oral

1.5

156.4

9236

61908

A10BA02

ATC

metformin; oral

1.5

156.3

6064

37305

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

13.1

156.2

163

107

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

10.0

155.8

192

165

WPA13, ,

SPAT

20.3

155.6

132

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.1

155.6

715

2043

SPAT1325

SPAT

Vaccination

1.5

155.5

6756

42564

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

6.3

155.5

278

379

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.3

155.4

1226

4609

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

3.7

155.4

519

1209

XA402

NOMESCO Finland

ENMG

3.6

155.4

540

1293

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

7.7

155.0

233

261

158

Kela drug reimbursment

Everolimus

29.9

155.0

115

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

154.7

605

1566

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

20.9

154.0

129

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

7.1

154.0

249

304

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

4.4

153.9

413

817

K56.7

ICD-10 Finland

Ileus, unspecified

3.8

153.4

497

1133

L02

ICPC

Back symptom/complaint

2.0

153.3

1729

7506

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.3

153.1

421

849

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

11.0

152.4

177

139

H05AA02

ATC

teriparatide; parenteral

12.5

152.2

163

112

L01XE04

ATC

[U] sunitinib

15.6

152.2

145

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

5.2

151.7

334

558

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.4

151.6

573

1451

198

Kela drug reimbursment

Sorafenib

14.8

151.4

148

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

7.0

151.2

247

305

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

6.9

151.2

250

313

N06AX26

ATC

vortioxetine; oral

2.3

151.0

1264

4875

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.1

150.9

1538

6425

RD210, ,

NOMESCO Finland

4.7

150.6

369

677

L01EX05

ATC

regorafenib; oral

28.0

150.5

114

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

8.7

150.3

205

203

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.4

150.0

1154

4290

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.8

149.4

811

2543

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.9

149.2

736

2190

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.0

148.8

703

2041

U05

ICPC

Urination problems other

2.3

148.7

1217

4647

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

148.5

871

2844

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

11.3

148.2

169

129

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

5.9

147.7

284

417

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.6

147.6

514

1232

WW300

NOMESCO Finland

Transfer of autologic stem cells

9.9

146.7

182

158

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

10.7

146.1

172

138

RD211, ,

NOMESCO Finland

2.6

145.9

937

3201

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

4.0

145.8

447

979

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.2

145.4

317

525

Z51.0

ICD-10 Finland

Radiotherapy session

4.1

145.3

424

895

H02BX01

ATC

methylprednisolone, combinations; systemic

2.5

144.8

1026

3673

ZXD35

NOMESCO Finland

Usual procedure

3.0

144.7

668

1913

SPAT1110

SPAT

Measurement of pain intensity

6.6

144.6

249

326

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.1

144.5

630

1744

M79.1

ICD-10 Finland

Myalgia

1.8

144.4

2497

12483

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

144.3

2661

13559

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

144.1

2446

12160

P03

ICPC

Feeling depressed

2.1

144.0

1456

6061

JAL30

NOMESCO Finland

Omentectomy

4.8

143.6

346

626

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.2

143.5

1315

5264

R07.3

ICD-10 Finland

Other chest pain

1.9

143.0

2003

9369

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

4.5

143.0

375

728

S76

ICPC

Skin infection other

2.3

143.0

1159

4406

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.8

142.9

281

422

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

142.8

1865

8521

M01AB01

ATC

indometacin; systemic, rectal

2.1

142.5

1515

6428

A10AE05

ATC

insulin detemir; parenteral

2.4

142.3

1105

4122

AN1

Coronary angiography

1.8

141.8

2371

11729

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

141.8

3916

22207

SPAT1139

SPAT

Nutrition survey

2.8

141.7

750

2319

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

12.8

141.7

150

101

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.3

141.7

1112

4168

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.6

141.6

871

2912

XG466

NOMESCO Finland

Sleep oxymetry

2.9

141.6

702

2094

J46

ICD-10 Finland

Status asthmaticus

3.3

141.2

573

1518

RS221, ,

NOMESCO Finland

4.7

141.0

347

639

JFF23

NOMESCO Finland

Transversostomy

4.3

140.7

386

777

EBA10

NOMESCO Finland

Operative extraction of tooth

1.9

140.6

2008

9451

EBA00

NOMESCO Finland

Extraction of tooth

1.5

140.2

6869

44136

L90

ICPC

Osteoarthrosis of knee

2.2

140.0

1303

5247

K59.0

ICD-10 Finland

Constipation

2.2

139.8

1217

4769

NB1AD

NOMESCO Finland

Shoulder CT examination

4.4

139.7

372

731

A01AB09

ATC

miconazole; local oral

2.0

139.3

1671

7408

L02BG04

ATC

letrozole; oral

2.1

139.1

1449

6099

NG1AD

NOMESCO Finland

Knee CT examination

4.5

139.1

363

702

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

7.5

138.9

212

242

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.5

138.7

500

1227

Z50.1

ICD-10 Finland

Other physical therapy

2.4

138.7

1075

4007

UJD02

NOMESCO Finland

Gastroscopy

2.4

138.4

1014

3685

NGC30

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, special prosthesis

9.9

138.2

172

150

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

19.9

138.1

118

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.6

137.9

476

1134

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.7

137.8

341

631

G04BD12

ATC

mirabegron; oral

1.8

137.8

2494

12627

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

7.4

137.7

215

252

X76

ICPC

Malignant neoplasm breast female

3.4

137.6

519

1312

SPAT1202

SPAT

Intra-articular injection

3.1

137.6

627

1782

L84

ICPC

Back syndrome without radiat pain

2.6

137.5

855

2874

N05CD08

ATC

midazolam; nasal, systemic

3.4

137.4

528

1351

M02AA10

ATC

ketoprofen; topical

1.7

137.1

2977

15862

TJF80

NOMESCO Finland

Ostomy education

4.4

136.7

363

712

RF210, ,

NOMESCO Finland

3.4

136.6

516

1306

M54.2

ICD-10 Finland

Cervicalgia

2.1

136.4

1372

5696

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.4

136.3

285

454

A03

ICPC

Fever

1.7

136.1

2883

15254

205

Kela drug reimbursment

Chronic hypertension

1.5

136.1

5786

36084

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.1

136.0

616

1744

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.1

135.9

620

1763

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.5

135.7

885

3045

L17

ICPC

Foot/toe symptom/complaint

1.5

135.6

5694

35417

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

4.9

135.5

317

559

WX704

NOMESCO Finland

Intubation

2.0

135.3

1647

7338

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.2

135.1

1189

4678

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

5.4

134.6

281

447

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

9.1

133.9

177

168

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

133.9

13456

98306

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

23.6

133.5

107

WW200

NOMESCO Finland

Immunization

3.0

132.7

610

1742

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

3.1

132.5

580

1609

N06AX12

ATC

bupropion; oral

2.4

132.4

1029

3838

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

132.2

7144

46654

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

12.1

132.1

144

102

M90.7*C90.0

ICD-10 Finland

Pathological fracture in multiple myeloma

49.8

132.0

G44.2

ICD-10 Finland

Tension-type headache

1.8

131.8

2193

10820

XX1XQ

NOMESCO Finland

Other SPECT-CT

27.7

131.6

100

KA3EB

NOMESCO Finland

Antegrade pyelography

7.4

131.2

204

238

D07AC01

ATC

betamethasone; topical

1.5

130.9

7131

46617

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.9

130.7

664

2007

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.9

130.7

653

1956

M01AH03

ATC

valdecoxib; oral

2.3

130.4

1129

4411

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

5.6

130.3

261

399

D70.89

ICD-10 Finland

Neutropenic splenomegaly

4.4

130.3

349

689

B01AX06

ATC

[U] rivaroxaban

3.9

129.5

405

900

SPAT1151

SPAT

Treatment of major wounds

4.6

129.3

329

623

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.2

129.1

547

1488

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.0

129.1

1543

6827

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

129.0

1715

7873

L14

ICPC

Leg/thigh symptom/complaint

2.0

128.9

1586

7088

N03AX14

ATC

levetiracetam; systemic

2.8

128.9

698

2184

ZXA10

NOMESCO Finland

Bilateral

1.6

128.8

3594

20380

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

5.8

128.7

251

374

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.4

128.7

347

689

WX872

NOMESCO Finland

Intensive care

2.2

128.6

1153

4570

K07

ICPC

Swollen ankles/oedema

2.3

128.5

1048

3992

M46.4

ICD-10 Finland

Discitis, unspecified

9.7

128.5

162

144

M01AX01

ATC

nabumetone; oral

2.6

128.2

785

2617

WPA10, ,

SPAT

11.0

127.6

148

116

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.0

127.2

382

824

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.8

127.2

413

943

C09AA05

ATC

ramipril; oral

1.5

127.0

5401

33600

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.4

126.8

494

1275

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.6

126.8

801

2712

B01AF02

ATC

apixaban; oral

1.7

126.5

2896

15621

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.6

126.1

442

1064

M43.0

ICD-10 Finland

Spondylolysis

4.4

125.7

337

666

XX2CT

NOMESCO Finland

Other injection with CT guidance

22.1

125.6

103

322

Kela drug reimbursment

Sunitinib

14.1

125.5

126

K08.3

ICD-10 Finland

Retained dental root

1.9

125.5

1683

7746

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

125.4

1787

8391

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

7.1

125.1

200

241

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

125.0

4525

27202

ZX050

NOMESCO Finland

Stereotactic radiotherapy

5.3

125.0

267

434

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

9.3

124.8

162

150

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

8.2

124.7

178

187

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

8.6

124.5

171

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

4.3

124.2

340

683

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

4.9

124.2

288

504

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

2.9

124.1

626

1885

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

16.5

123.9

115

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

19.8

123.8

106

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.4

123.1

928

3413

5BX04, ,

NOMESCO Finland

29.2

123.1

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.1

123.0

557

1577

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

6.5

122.6

212

279

WVA20, ,

SPAT

2.6

122.4

777

2637

WX200

NOMESCO Finland

Interscalenous plexus blockade

4.0

122.4

375

821

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

9.4

122.4

157

143

R81

ICPC

Pneumonia

2.5

122.3

840

2961

WPA41

NOMESCO Finland

Psychosocial conversational support in palliative care

21.7

122.2

101

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

122.1

1295

5481

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.3

122.0

987

3745

A10BH01

ATC

sitagliptin; oral

1.8

121.7

1975

9659

L01EX07

ATC

cabozantinib; oral

15.2

121.4

117

L02BA01

ATC

tamoxifen; oral

2.4

121.3

862

3087

C07AB02

ATC

metoprolol; systemic

1.5

121.2

4177

24824

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.2

121.1

518

1417

M53.2

ICD-10 Finland

Spinal instabilities

7.5

120.8

185

212

K92.0

ICD-10 Finland

Haematemesis

3.0

120.8

560

1607

L15

ICPC

Knee symptom/complaint

1.5

120.7

4366

26215

TAC00

NOMESCO Finland

Peripheral nerve block

10.9

120.5

140

110

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

16.7

120.5

111

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

4.9

120.2

280

492

NGC60

NOMESCO Finland

Exchange or addition of patellar part

18.0

120.1

107

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

120.0

1401

6142

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.0

119.6

1385

6054

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.6

119.5

241

371

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

119.2

8406

57308

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.3

119.0

474

1241

Z2221

NOMESCO Finland

Medical doctor

1.5

118.7

4848

29843

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

4.3

118.7

325

653

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

4.6

118.5

302

573

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.1

118.4

343

720

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

10.9

118.4

138

109

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

4.8

118.4

281

502

L01BA01

ATC

methotrexate; systemic

2.7

118.0

680

2198

1BA04, ,

NOMESCO Finland

25.5

117.9

N03AF02

ATC

oxcarbazepine; oral

2.7

117.8

667

2136

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.3

117.7

962

3665

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

9.0

117.5

156

149

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.3

117.3

993

3840

NGT60

NOMESCO Finland

Forcible manipulation of knee joint

8.2

117.3

167

175

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

4.3

117.0

319

639

Y96.9

ICD-10 Finland

Unspecified type of accident

3.5

116.8

422

1037

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

9.0

116.8

155

148

M01AE51

ATC

ibuprofen, combinations; systemic

4.3

116.6

316

630

G04BD08

ATC

solifenacin; oral

2.0

116.4

1308

5654

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

116.3

1996

9920

E66.00

ICD-10 Finland

Metabolic syndrome

2.2

116.3

1050

4170

R03BA05

ATC

fluticasone; inhalant

1.6

115.6

3109

17431

C10AC01

ATC

colestyramine; oral

3.0

115.5

543

1571

WX600

NOMESCO Finland

Single shot through catheter

3.8

115.3

369

834

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

5.7

114.8

227

343

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.7

114.7

669

2176

NFJ60

NOMESCO Finland

Internal fixation of fracture of other parts of femur with intramedullary nail

5.8

114.5

221

326

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.2

114.3

318

647

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.8

114.3

611

1898

M13.9

ICD-10 Finland

Arthritis, unspecified

2.0

114.2

1363

6020

191

Kela drug reimbursment

Erlotinib

14.2

114.1

114

G83.4

ICD-10 Finland

Cauda equina syndrome

10.1

113.8

139

118

D12

ICPC

Constipation

2.4

113.7

804

2872

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

4.0

113.4

339

729

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

12.9

113.3

119

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

113.3

8477

58224

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.5

113.2

295

570

115

Kela drug reimbursment

Breast cancer

1.8

113.2

1726

8272

PD4AD

NOMESCO Finland

CT of lower extremity arteries

5.0

113.0

256

439

WPA43

NOMESCO Finland

A doctor's home visit to perform palliative care

21.2

112.9

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

112.8

1747

8412

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.3

112.5

243

399

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

5.3

112.4

239

387

D01

ICPC

Abdominal pain/cramps general

1.8

112.3

2052

10384

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

112.3

4805

29809

UJC12

NOMESCO Finland

Flexible oesophagoscopy

5.3

112.1

240

391

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.8

112.0

599

1861

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

7.7

111.9

168

188

WPA15, ,

SPAT

25.7

111.8

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

7.0

111.8

182

224

E66.9

ICD-10 Finland

Obesity, unspecified

2.8

111.8

592

1830

S28

ICPC

Limited function/disability (S)

5.7

111.7

221

334

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

6.4

111.7

196

262

S72.3

ICD-10 Finland

Fracture of shaft of femur

5.4

111.6

236

380

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

5.4

111.6

235

377

A10BH05

ATC

linagliptin; oral

2.1

111.5

1133

4715

JFB00

NOMESCO Finland

Partial resection of small intestine

3.4

111.3

435

1125

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

5.2

111.1

244

407

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

111.0

3701

21784

R04.2

ICD-10 Finland

Haemoptysis

2.5

110.9

757

2659

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

6.9

110.8

183

229

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

3.8

110.7

357

811

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.3

110.7

888

3355

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.6

110.7

708

2411

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

14.3

110.6

110

WPA16, ,

SPAT

20.2

110.6

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.1

110.6

481

1329

Y79.2

ICD-10 Finland

Orthopaedic devices associated with adverse incidents, prosthetic and other implants, materials and accessory devices

11.4

110.6

125

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.0

110.5

523

1519

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.4

110.4

292

571

J05AB01

ATC

aciclovir; systemic

1.5

110.1

3960

23689

ECB20

NOMESCO Finland

Oral alveoplasty

4.5

110.0

281

534

NF3AD

NOMESCO Finland

Femur CT

13.2

109.9

114

C07AA05

ATC

propranolol; systemic

1.6

109.6

3373

19496

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.4

108.9

820

3013

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

108.7

4648

28800

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

6.1

108.7

200

281

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

5.2

108.5

235

387

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

21.4

108.5

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.4

108.5

803

2928

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

108.5

5203

32967

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.5

108.4

699

2389

R4120

NOMESCO Finland

Occupational therapy

2.1

108.4

1171

4985

R95

ICPC

Chron obstructive pulmonary disease

2.6

108.3

677

2279

RF220, ,

NOMESCO Finland

4.3

108.3

299

605

RF420, ,

NOMESCO Finland

4.4

108.1

283

549

WPA45, ,

SPAT

50.7

108.0

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

18.5

108.0

N06AX05

ATC

trazodone; oral

3.3

107.8

442

1178

YX9AW, ,

NOMESCO Finland

5.9

107.8

205

298

ZXC95

NOMESCO Finland

Use of surgical navigator

4.4

107.5

288

569

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

7.2

107.5

171

205

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.7

107.3

630

2055

C50.99

ICD-10 Finland

Breast, unspecified

2.7

107.3

635

2080

M87.9

ICD-10 Finland

Osteonecrosis, unspecified

8.1

107.3

154

163

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

3.4

107.1

403

1017

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

4.1

107.1

312

658

Z08

ICPC

Social welfare problem

4.2

107.0

301

618

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

106.7

12768

94218

M05BA07

ATC

risedronic acid; oral

2.6

106.6

635

2087

TGD00

NOMESCO Finland

Needle biopsy of lung

6.7

106.5

180

231

M15

ICD-10 Finland

Polyarthrosis

2.3

106.1

890

3427

A03FA02

ATC

cisapride; oral, rectal

1.9

106.0

1392

6349

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.3

106.0

417

1083

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

7.4

105.9

165

193

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

105.9

6906

46200

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

10.5

105.7

126

103

SPAT1097

SPAT

Recording of ECG

1.6

105.7

2906

16349

JFF10

NOMESCO Finland

Loop enterostomy

5.9

105.7

202

295

N03A

ATC

ANTIEPILEPTICS

30.4

105.5

P01BA02

ATC

hydroxychloroquine; oral

1.9

105.5

1417

6513

L99

ICPC

Musculoskeletal disease other

3.1

105.4

459

1269

R41.0

ICD-10 Finland

Disorientation, unspecified

2.5

105.4

724

2550

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.9

105.4

202

296

AA1AA

NOMESCO Finland

Head X-ray examination

5.2

105.3

232

388

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

9.5

105.1

134

121

R42

ICD-10 Finland

Dizziness and giddiness

1.5

104.7

4480

27734

K86.1

ICD-10 Finland

Other chronic pancreatitis

5.0

104.6

239

413

WZA00

NOMESCO Finland

Concise certificate

2.1

104.4

1008

4110

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

14.5

104.3

103

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

9.6

104.3

132

118

SPAT1360

SPAT

Extensive global examination

1.9

104.2

1407

6478

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

9.4

103.9

134

123

EB4VA, ,

NOMESCO Finland

0.5

103.8

1173

18516

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

4.4

103.8

274

535

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

6.6

103.8

179

235

SPAT1281

SPAT

Other administrative function

1.9

103.7

1436

6665

A02BA04

ATC

nizatidine; systemic

1.9

103.7

1431

6636

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.9

103.6

502

1477

C03AA03

ATC

hydrochlorothiazide; oral

1.8

103.6

1821

9101

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

7.3

103.6

163

193

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.4

103.4

396

1011

RS220, ,

NOMESCO Finland

4.4

103.2

273

534

OAB48, ,

SPAT

0.4

103.2

724

13479

ACC51

NOMESCO Finland

Release of median nerve

2.0

103.0

1208

5297

R03DC03

ATC

montelukast; oral

1.6

102.9

2605

14359

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.4

102.8

386

973

M10.9

ICD-10 Finland

Gout, unspecified

1.9

102.8

1385

6371

N03AG01

ATC

valproic acid; systemic, rectal

2.1

102.7

1096

4643

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.8

102.5

247

447

B82

ICPC

Anaemia other/unspecified

2.6

102.4

633

2119

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.4

102.4

398

1026

I50

ICD-10 Finland

Heart failure

2.5

102.3

673

2322

G04BD04

ATC

oxybutynin; oral, transdermal

2.1

102.2

988

4030

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.7

102.1

1933

9867

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

3.3

102.0

408

1071

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

102.0

1099

4673

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.7

101.8

578

1853

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

12.7

101.8

108

RS222, ,

NOMESCO Finland

4.4

101.5

269

527

R85

ICPC

Malignant neopl respiratory other

16.5

101.3

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.0

101.3

1252

5592

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.7

101.3

572

1829

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

13.0

101.2

106

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

101.0

974

3969

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.5

101.0

672

2332

343

Kela drug reimbursment

Pazopanib

22.7

100.9

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.4

100.8

388

994

N03AX11

ATC

topiramate; oral

3.5

100.7

374

936

R03DA04

ATC

theophylline; systemic, rectal

2.1

100.7

993

4082

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.3

100.4

794

2980

TGA30

NOMESCO Finland

Thoracocentesis

4.8

100.3

237

422

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.9

100.2

1487

7056

L08

ICPC

Shoulder symptom/complaint

1.5

100.0

3938

23950

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.7

99.9

1897

9689

WPA42

NOMESCO Finland

Family-centered psychosocial intervention in palliative care

26.4

99.8

M01AC01

ATC

piroxicam; systemic, rectal

1.6

99.5

2392

13009

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

8.5

99.4

138

140

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

9.6

99.3

126

113

ZX120, ,

SPAT

3.4

99.3

370

928

X57

ICD-10 Finland

Unspecified privation

3.1

99.3

445

1252

A03CA02

ATC

clidinium and psycholeptics; oral

2.1

99.2

1080

4608

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.6

99.2

615

2062

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.3

99.1

389

1009

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

12.9

99.1

104

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.7

98.9

556

1774

R03AC13

ATC

formoterol; inhalant

2.2

98.7

901

3592

168

Kela drug reimbursment

Axitinib

28.8

98.5

E83.50

ICD-10 Finland

Hypercalcemia

3.5

98.5

364

908

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

98.4

7211

49037

ZX100

NOMESCO Finland

Oral

3.6

98.4

345

831

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

3.7

98.2

325

752

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

5.8

98.2

190

281

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

98.1

1886

9666

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

6.4

97.9

173

233

L03.9

ICD-10 Finland

Cellulitis, unspecified

3.0

97.9

452

1294

A99

ICPC

Disease/condition unspecnature/site

1.7

97.7

1984

10322

J45.8

ICD-10 Finland

Mixed asthma

2.7

97.5

569

1850

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.8

97.4

504

1538

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.5

97.4

666

2341

N05AX08

ATC

risperidone; systemic

1.8

97.3

1695

8444

TQW80

NOMESCO Finland

Local dermatologic skincare

2.6

97.2

587

1942

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.8

97.2

505

1545

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.3

97.0

205

330

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

97.0

2191

11724

NH1AD

NOMESCO Finland

Ankle and foot CT

3.2

96.9

415

1136

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

5.9

96.9

186

273

N06AX22

ATC

agomelatine; oral

3.4

96.8

362

910

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

6.6

96.7

165

214

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

5.4

96.7

203

325

NGC00

NOMESCO Finland

Exchange of a loose part of prosthesis in knee joint

9.0

96.6

128

122

P18

ICPC

Medication abuse

7.3

96.6

152

180

F34.1

ICD-10 Finland

Dysthymia

2.6

96.4

585

1940

L60.0

ICD-10 Finland

Ingrowing nail

2.2

96.4

840

3285

L01XE11

ATC

[U] pazopanib

19.0

96.4

J05AB11

ATC

valaciclovir; oral

1.6

96.3

2642

14833

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

96.2

1034

4391

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.8

96.1

307

693

HAC20

NOMESCO Finland

Total mastectomy

2.2

96.0

868

3446

R60.1

ICD-10 Finland

Generalized oedema

5.7

95.8

188

282

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.2

95.8

271

559

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.9

95.5

486

1470

L95

ICPC

Osteoporosis

2.2

95.3

817

3173

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

95.3

1904

9858

R03BA01

ATC

beclometasone; inhalant

1.6

95.2

2421

13343

SPAT1251

SPAT

Organisation of medication

2.4

95.2

698

2533

J01DA09

ATC

[U] cefadroxil

1.4

95.2

4596

29043

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.5

95.1

345

850

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

95.0

1680

8403

XQ902

NOMESCO Finland

Other photography

4.1

95.0

273

570

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

3.0

94.9

446

1290

L02AE03

ATC

goserelin; implant

3.8

94.8

303

684

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.1

94.8

928

3803

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

94.7

1592

7845

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

12.1

94.5

103

AN2

Balloon angioplasty, including several vessels

2.6

94.2

594

2008

Z43.5

ICD-10 Finland

Attention to cystostomy

5.3

94.1

202

330

NFJ62

NOMESCO Finland

Internal fixation of fracture of other parts of femur with plate

5.7

94.1

186

281

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

4.1

94.1

273

574

WF099

NOMESCO Finland

Other radiotherapy

5.3

94.0

200

324

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.7

94.0

1901

9873

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

7.2

94.0

149

178

L01BC53

ATC

tegafur, combinations; systemic

15.0

93.8

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

7.1

93.8

150

181

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

93.7

1061

4591

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

5.0

93.5

212

364

K02.1

ICD-10 Finland

Caries of dentine

1.3

93.4

10656

77360

P76

ICPC

Depressive disorder

2.1

93.4

932

3847

340

Kela drug reimbursment

Everolimus

27.7

93.4

R55

ICD-10 Finland

Syncope and collapse

1.6

93.3

2241

12174

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

16.2

93.1

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.5

93.1

624

2172

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

5.6

93.1

188

290

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

93.0

802

3123

L01XE26

ATC

[U] cabozantinib

25.0

93.0

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

92.9

3403

20355

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.9

92.8

291

648

N19

ICD-10 Finland

Unspecified kidney failure

2.2

92.5

800

3119

OAA80, ,

SPAT

0.3

92.3

286

7691

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

10.4

92.3

111

D64.8

ICD-10 Finland

Other specified anaemias

3.0

92.2

434

1256

Z00.0

ICD-10 Finland

General medical examination

1.5

92.0

3642

22130

NGC20

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, normal prosthesis

9.8

92.0

115

101

S73.0

ICD-10 Finland

Dislocation of hip

6.3

92.0

165

226

SPAT1127

SPAT

Enema

4.8

91.8

219

393

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.9

91.8

286

634

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.2

91.8

852

3418

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

7.9

91.8

134

145

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

4.3

91.7

250

501

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

91.7

1446

6988

M70.7

ICD-10 Finland

Other bursitis of hip

2.9

91.6

446

1316

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

91.4

1271

5901

I20.09

ICD-10 Finland

Unstable angina

2.0

91.3

1138

5094

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

6.8

91.3

152

192

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.9

91.2

280

614

M84.1

ICD-10 Finland

Nonunion of fracture [pseudarthrosis]

6.2

91.2

165

228

L04AA06

ATC

mycophenolic acid; systemic

3.2

91.2

387

1054

R35

ICD-10 Finland

Polyuria

1.9

91.1

1342

6348

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

91.1

840

3361

L04AX01

ATC

azathioprine; systemic

2.3

90.9

733

2774

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

90.8

3460

20857

R03AC03

ATC

terbutaline; inhalant

1.6

90.7

2284

12548

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.6

90.6

566

1904

RF410, ,

NOMESCO Finland

4.4

90.5

243

481

Y94.0

ICD-10 Finland

Accident at home

3.1

90.5

393

1085

YNB10

NOMESCO Finland

Collection of stem cells for transplant

14.3

90.5

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

2.8

90.4

478

1476

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.9

90.0

1162

5264

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

3.3

90.0

351

907

L01EX01

ATC

sunitinib; oral

14.4

89.8

ACC53

NOMESCO Finland

Release of ulnar nerve

4.2

89.8

253

520

207

Kela drug reimbursment

Chronic arrhythmias

1.5

89.8

3243

19327

NFB60

NOMESCO Finland

Demanding prosthetic replacement of hip

7.3

89.8

140

164

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

9.2

89.8

117

109

R03AC12

ATC

salmeterol; inhalant

2.2

89.5

822

3283

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.6

89.4

308

733

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

89.4

2037

10912

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

5.8

89.4

173

256

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

7.0

89.3

145

178

H03AA01

ATC

levothyroxine sodium; systemic

1.4

89.3

4246

26711

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

3.4

89.0

341

871

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

89.0

1084

4813

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

5.3

89.0

190

309

U08

ICPC

Urinary retention

2.7

89.0

512

1653

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

8.9

88.9

119

115

3030

Kela drug reimbursment

Abemaciclib

11.3

88.6

101

D07AD01

ATC

clobetasol; topical

1.5

88.6

3106

18393

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

9.1

88.5

116

109

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.4

88.4

234

458

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

88.3

1140

5163

G54.0

ICD-10 Finland

Brachial plexus disorders

3.1

88.2

384

1062

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.3

88.0

687

2563

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

88.0

10079

72967

1515, ,

Kela drug reimbursment

11.1

87.9

101

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

5.2

87.9

193

322

L05

ICPC

Flank/axilla symptom/complaint

1.9

87.9

1115

5020

WPA11, ,

SPAT

16.5

87.5

L01AA03

ATC

melphalan; systemic

12.4

87.5

JKA20

NOMESCO Finland

Cholecystectomy

2.5

87.4

576

1989

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.5

87.3

601

2118

K85.8

ICD-10 Finland

Other acute pancreatitis

5.1

87.3

193

324

U28

ICPC

Limited function/disability (U)

3.9

87.2

266

581

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

18.3

87.1

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

5.7

87.0

172

260

K29.7

ICD-10 Finland

Gastritis, unspecified

2.3

86.8

682

2552

D07AB08

ATC

desonide; topical

1.7

86.6

1877

9922

C08CA05

ATC

nifedipine; systemic

1.9

86.6

1197

5546

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

30.5

86.6

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

8.0

86.5

126

136

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

13.1

86.3

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

4.1

86.2

252

533

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.0

86.2

957

4110

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.7

86.2

473

1490

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.0

86.1

262

571

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

86.1

1302

6208

R5140, ,

SPAT

3.5

85.7

311

767

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.2

85.5

751

2945

NG1DA

NOMESCO Finland

X-ray of knees

3.6

85.2

301

729

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.4

85.1

318

799

N05BE01

ATC

buspirone; oral

2.6

85.1

512

1691

155

Kela drug reimbursment

Afatinib and gefitinib

14.8

85.1

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.5

85.0

549

1877

WPA40

NOMESCO Finland

Individual-centered psychosocial intervention in palliative care

22.7

85.0

M48.9

ICD-10 Finland

Spondylopathy, unspecified

6.4

85.0

150

202

UJC01

NOMESCO Finland

Scopy of lower throat

4.0

84.8

250

532

G04BD07

ATC

tolterodine; oral

2.1

84.8

905

3830

HA1AA

NOMESCO Finland

X-ray mammography

1.8

84.8

1508

7548

R32

ICD-10 Finland

Unspecified urinary incontinence

2.5

84.7

546

1865

GA5AA

NOMESCO Finland

Rib X-ray examination

8.5

84.7

117

118

N07BB01

ATC

disulfiram; oral

2.3

84.6

707

2716

L04AX03

ATC

methotrexate; systemic

1.7

84.6

1608

8201

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.8

84.5

446

1376

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.9

84.4

260

572

U70

ICPC

Pyelonephritis/pyelitis

3.4

84.1

322

822

XX1AD

NOMESCO Finland

Other CT-examination

4.2

84.0

234

477

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

83.8

670

2526

N17.8

ICD-10 Finland

Other acute renal failure

3.4

83.5

312

784

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.0

83.4

249

535

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.2

83.4

353

960

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

3.3

83.2

327

849

M05BA06

ATC

ibandronic acid; systemic

2.9

83.2

401

1177

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

7.6

83.0

126

143

127

Kela drug reimbursment

Transplant complication

3.4

83.0

316

804

S72.4

ICD-10 Finland

Fracture of lower end of femur

4.8

83.0

196

349

L01EF03

ATC

abemaciclib; oral

10.8

83.0

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.7

82.9

274

634

TJD20

NOMESCO Finland

Change of gastrostomy tube

6.5

82.8

143

188

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

5.1

82.7

185

314

L01XE10

ATC

[U] everolimus

30.7

82.7

M41.9

ICD-10 Finland

Scoliosis, unspecified

4.0

82.7

244

520

GBB00

NOMESCO Finland

Tracheostomy

3.5

82.6

301

744

A08AB01

ATC

orlistat; oral

5.8

82.6

161

240

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.6

82.6

208

391

G47.3

ICD-10 Finland

Sleep apnoea

1.4

82.5

4057

25629

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

17.6

82.3

RF120, ,

NOMESCO Finland

4.2

82.2

231

474

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

3.9

82.2

253

556

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

4.3

82.1

222

442

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

2.3

82.1

667

2532

A11CC03

ATC

alfacalcidol; systemic

2.6

82.1

489

1607

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.0

82.0

387

1122

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

7.2

81.9

129

153

KH1AD

NOMESCO Finland

CT of urinary organs

2.2

81.8

698

2705

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

12.4

81.8

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

81.7

861

3626

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.1

81.7

872

3690

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.1

81.7

355

981

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.0

81.6

392

1148

-1, ,

NOMESCO Finland

1.4

81.6

5383

35756

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

5.1

81.5

180

302

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.0

81.5

247

537

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

5.9

81.4

154

223

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.7

81.3

3208

37611

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

81.2

2021

11055

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

3.8

81.2

260

588

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.7

81.1

463

1489

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.8

81.1

1227

5849

160

Kela drug reimbursment

exenatide

3.1

81.1

361

1012

JDE00

NOMESCO Finland

Gastrojejunostomy

9.4

80.9

104

M01AB08

ATC

etodolac; oral

1.9

80.9

1149

5367

NFH30

NOMESCO Finland

Reduction of dislocation prosthesis of hip joint, closed

6.4

80.9

142

190

V03AE02

ATC

sevelamer; oral

6.0

80.7

151

216

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

3.7

80.7

271

634

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

6.4

80.6

141

188

L01XE03

ATC

[U] erlotinib

12.8

80.5

X77

ICPC

Malignant neopl genital female other

8.0

80.5

117

126

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.4

80.4

611

2252

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

4.3

80.4

221

446

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.6

80.3

278

664

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

5.0

80.3

183

316

A10BB12

ATC

glimepiride; oral

1.8

80.2

1343

6602

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

5.3

80.1

170

275

ZXD40

NOMESCO Finland

Procedure on patient requiring isolation

7.9

79.9

117

127

R03BA02

ATC

budesonide; inhalant

1.5

79.9

2927

17458

D69.5

ICD-10 Finland

Secondary thrombocytopenia

7.7

79.9

119

132

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.7

79.9

262

603

S72.2

ICD-10 Finland

Subtrochanteric fracture

4.4

79.8

211

413

J01FA09

ATC

clarithromycin; systemic

1.4

79.7

5205

34495

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.3

79.6

618

2300

323

Kela drug reimbursment

Sorafenib

14.0

79.6

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

6.6

79.5

136

177

8140/3-C16.0

ICD-O-3

Adenocarcinoma, NOS, of cardia, NOS

9.4

79.5

102

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

11.2

79.4

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

79.3

1004

4514

NAW10

NOMESCO Finland

Reoperation for superficial infection in in surgery of spine or neck

25.3

79.2

JG1CG

NOMESCO Finland

Extensive MRI of rectum

4.7

79.2

195

360

K10.3

ICD-10 Finland

Alveolitis of jaws

2.2

79.0

682

2655

WX210

NOMESCO Finland

Plexus blockade of nervus ichiadicus

7.7

78.7

118

132

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

78.4

2085

11586

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.4

78.4

165

265

KCD02

NOMESCO Finland

Transurethral resection of bladder

2.4

78.3

556

1988

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

78.3

735

2961

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

10.3

78.1

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.4

78.1

558

2001

E000006, ,

ATC

1.8

78.0

1185

5654

WW409

NOMESCO Finland

Other aferesis

9.0

77.9

103

398

Kela drug reimbursment

Ixazomib

36.2

77.8

NBG10

NOMESCO Finland

Acromioplastia

2.7

77.6

447

1444

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

12.5

77.5

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

7.6

77.5

117

132

NBB10

NOMESCO Finland

Primary partial prosthetic replacement of humero-scapular joint not using cement, other or unspecified

7.1

77.4

124

150

K78

ICPC

Atrial fibrillation/flutter

1.7

77.4

1542

7961

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

10.5

77.4

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.3

77.3

308

807

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.8

77.0

1191

5713

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

5.8

76.9

149

221

K85

ICD-10 Finland

Acute pancreatitis

3.1

76.8

333

919

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

76.8

1094

5115

R5130, ,

SPAT

6.6

76.7

132

173

E66.0

ICD-10 Finland

Obesity due to excess calories

4.2

76.6

218

452

N18.8

ICD-10 Finland

Other chronic renal failure

2.5

76.5

509

1766

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

4.6

76.2

189

351

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.3

76.2

588

2183

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

76.1

1943

10687

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.4

75.8

537

1918

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

9.6

75.8

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

75.7

3936

25067

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

75.7

13240

100660

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.3

75.6

586

2179

N06AA06

ATC

trimipramine; systemic

2.7

75.5

414

1304

B02AA02

ATC

tranexamic acid; systemic

1.5

75.4

2332

13407

U29

ICPC

Urinary symptom/complaint other

2.3

75.3

629

2415

JEA00

NOMESCO Finland

Appendectomy

1.9

75.3

1035

4783

L04AA13

ATC

[U] leflunomide

2.7

75.3

413

1301

G54.6

ICD-10 Finland

Phantom limb syndrome with pain

43.7

75.2

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

75.2

2639

31710

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

11.2

75.2

SPAT1053

SPAT

Memory test

1.5

75.1

2889

17387

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

6.8

75.1

125

158

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

7.9

74.9

110

120

A10BJ02

ATC

liraglutide; parenteral

2.5

74.8

487

1672

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

4.4

74.8

196

381

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.3

74.6

604

2289

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

6.7

74.5

126

162

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

3.7

74.5

244

561

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

4.9

74.5

174

307

QDB10, ,

SPAT

2.4

74.5

521

1850

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

74.3

1435

7342

GAC01

NOMESCO Finland

Endoscopic biopsy of pleura

8.6

74.3

102

N29

ICPC

Neurological sympt/complt other

2.8

74.3

394

1219

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

4.5

74.1

193

373

L01XE05

ATC

[U] sorafenib

12.9

74.1

ZX114

NOMESCO Finland

Intramuscular

3.3

74.1

292

760

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

2.0

74.1

805

3429

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

5.3

74.0

157

254

1505

Kela drug reimbursment

Ixazomib

37.1

74.0

SPAT1312

SPAT

General health counselling

1.4

73.9

5532

37376

WX722

NOMESCO Finland

PEEP

2.0

73.9

862

3767

L89

ICPC

Osteoarthrosis of hip

2.2

73.9

633

2457

L71

ICPC

Malignant neoplasm musculoskeletal

20.0

73.9

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

5.7

73.8

145

218

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.0

73.4

343

989

N06AB05

ATC

paroxetine; oral

1.9

73.2

944

4270

J01MA06

ATC

norfloxacin; oral

1.5

73.0

2218

12694

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.5

73.0

185

350

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.9

72.9

368

1108

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

4.7

72.9

177

323

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

2.9

72.9

367

1104

N05AB01

ATC

dixyrazine; systemic

3.6

72.9

256

618

N05BA02

ATC

chlordiazepoxide; systemic

2.6

72.8

428

1397

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

19.3

72.8

9052/3-C38.4

ICD-O-3

Epithelioid mesothelioma, malignant of pleura, NOS

20.9

72.8

XKC03

NOMESCO Finland

Water cystometry

2.4

72.7

536

1949

N18

ICPC

Paralysis/weakness

2.6

72.7

428

1398

N06AG02

ATC

moclobemide; oral

2.1

72.6

743

3094

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

7.2

72.5

114

135

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

2.7

72.4

421

1367

WX610, ,

SPAT

27.7

72.3

Z72.0

ICD-10 Finland

Tobacco use

2.5

72.3

462

1572

NA7AD

NOMESCO Finland

Spine CT

13.1

72.0

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

5.3

72.0

154

251

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

71.9

2348

13649

N06AX17

ATC

milnacipran; oral

4.2

71.9

201

411

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

6.0

71.9

134

191

J01MA01

ATC

ofloxacin; systemic

1.7

71.8

1484

7732

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

4.3

71.7

196

394

D07AC13

ATC

mometasone; topical

1.4

71.7

5165

34663

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.7

71.7

397

1257

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

2.9

71.6

348

1026

NHG20

NOMESCO Finland

Fusion of talocrural joint

6.0

71.6

133

189

A02BX02

ATC

sucralfate; oral

2.1

71.6

713

2939

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

71.5

768

3256

ZX108

NOMESCO Finland

Inhalation

4.5

71.3

184

353

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

3.3

71.2

277

715

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

31.8

71.1

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.8

71.0

1190

5845

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.8

71.0

373

1148

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

71.0

3001

18379

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

70.9

1542

8141

SPAT1101

SPAT

Orthostatic test

2.0

70.9

856

3785

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.6

70.9

243

577

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.7

70.9

400

1279

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

7.3

70.8

111

131

WX290

NOMESCO Finland

Other blockage of nerve

1.3

70.7

7685

54688

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.6

70.6

178

335

SPAT1138

SPAT

Guidance concerning bowel function

3.0

70.6

323

920

A96

ICPC

Death

4.7

70.6

173

318

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

70.6

707

2920

WX400

NOMESCO Finland

Inhalation anesthesy

2.2

70.6

625

2459

N18.0

ICD-10 Finland

End-stage renal disease

3.6

70.5

241

571

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

8.7

70.5

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.5

70.3

448

1522

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.7

70.2

406

1314

J01FA10

ATC

azithromycin; systemic

1.3

70.2

9709

71287

G44.0

ICD-10 Finland

Cluster headache syndrome

4.4

70.0

185

362

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

6.6

69.9

120

157

S80.0

ICD-10 Finland

Contusion of knee

1.8

69.8

1154

5645

L70

ICPC

Infection of musculoskeletal system

5.7

69.7

137

206

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

14.4

69.7

D09

ICPC

Nausea

2.2

69.7

652

2622

JCW98

NOMESCO Finland

Other transluminal endoscopic procedure on oesophagus

12.4

69.7

M80

ICD-10 Finland

Osteoporosis with pathological fracture

4.2

69.7

196

403

1220

FHL

Arthroscopy

2.2

69.5

651

2619

KA1FN

NOMESCO Finland

Isotope renography

4.4

69.5

183

357

Z71.8

ICD-10 Finland

Other specified counselling

1.3

69.2

5844

40117

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

69.0

725

3049

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

1.9

69.0

936

4305

3019

Kela drug reimbursment

Lenvatinib

14.1

68.8

S19

ICPC

Skin injury other

2.1

68.8

711

2971

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

68.8

5211

35199

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

68.8

800

3491

L04AD01

ATC

ciclosporin; systemic

3.0

68.6

326

949

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

68.6

1202

5980

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.0

68.6

316

904

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.4

68.5

181

354

C25

ICD-10 Finland

Malignant neoplasm of pancreas

13.2

68.5

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

4.5

68.4

174

330

V03AA01, ,

ATC

3.0

68.3

311

884

UJF92

NOMESCO Finland

Capsular endoscopy

2.8

68.2

372

1168

Z72.2

ICD-10 Finland

Drug use

8.1

68.2

104

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

8.1

68.2

104

N99

ICPC

Neurological disease other

3.2

68.1

279

744

NAG61

NOMESCO Finland

Posterior fusion of lumbar spine without fixation

11.6

68.1

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

68.0

1075

5189

C09AA02

ATC

enalapril; systemic

1.4

67.8

3812

24549

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

12.3

67.5

SAA04

NOMESCO Finland

Special examination of mouth

2.0

67.5

835

3723

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.5

67.5

441

1517

ZZR30

NOMESCO Finland

Flap of muscle

6.9

67.4

110

136

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

15.7

67.4

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.2

67.3

579

2251

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

9.5

67.3

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

67.1

560

2149

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

3.1

67.1

290

799

A06AC51

ATC

ispaghula, combinations; oral

2.0

67.1

818

3629

R39.1

ICD-10 Finland

Other difficulties with micturition

2.1

67.0

646

2629

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

4.7

66.9

165

305

N28

ICPC

Limited function/disability (N)

2.7

66.9

367

1156

L01EG02

ATC

everolimus; oral

34.3

66.9

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.6

66.9

405

1342

KAC10

NOMESCO Finland

Total nephrectomy with capsule

3.9

66.8

205

450

S20.2

ICD-10 Finland

Contusion of thorax

1.9

66.8

884

4032

212

Kela drug reimbursment

Gout

2.6

66.8

417

1403

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.7

66.7

163

299

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

4.5

66.6

169

320

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

66.6

1660

9066

QDE35

NOMESCO Finland

Repair of skin defect in lower limb after surgery or injury

6.1

66.6

122

171

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

66.5

1130

5572

W06

ICD-10 Finland

Fall involving bed

4.0

66.5

199

429

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

3.0

66.4

312

903

Z11

ICPC

Compliance/being ill problem

4.5

66.3

171

328

B37.08

ICD-10 Finland

Other candidal stomatitis

3.9

66.2

204

449

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

66.2

1097

5369

D02

ICPC

Abdominal pain epigastric

1.8

66.2

1017

4865

E000003, ,

ATC

2.0

66.0

724

3093

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

66.0

2976

18427

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.5

66.0

424

1447

NGC99

NOMESCO Finland

Other secondary prosthetic replacement inknee joint, other or unspecified

11.3

65.9

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

65.9

942

4405

N05CD02

ATC

nitrazepam; oral

2.9

65.9

317

930

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

65.8

969

4574

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

8.5

65.8

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

8.5

65.8

I95.9

ICD-10 Finland

Hypotension, unspecified

2.9

65.6

327

978

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

5.3

65.6

140

228

U07

ICPC

Urine symptom/complaint other

1.6

65.5

1543

8309

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.9

65.4

205

457

1508

Kela drug reimbursment

Lenvatinib

14.3

65.3

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.2

65.3

583

2301

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

8.1

65.3

100

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

11.6

65.3

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

9.4

65.2

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

3.9

65.0

200

440

SPAT1210

SPAT

Application of cast or individual aid

2.1

65.0

674

2821

T74.1

ICD-10 Finland

Physical abuse

3.4

64.9

249

637

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

3.0

64.9

294

833

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

64.8

1774

9905

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

64.8

1823

10243

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

64.7

2029

11679

K30

ICD-10 Finland

Functional dyspepsia

1.6

64.7

1875

10606

SPE90

NOMESCO Finland

Other partial denture

2.5

64.6

433

1508

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

2.4

64.5

460

1648

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.7

64.5

360

1145

SPF30

NOMESCO Finland

Relining of denture

2.7

64.4

368

1184

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

64.4

1598

8716

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.8

64.2

345

1075

K65.0

ICD-10 Finland

Acute peritonitis

3.2

64.2

261

693

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

2.8

64.1

334

1024

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.1

64.1

667

2795

M86.6

ICD-10 Finland

Other chronic osteomyelitis

6.3

64.1

114

155

PJA10

NOMESCO Finland

Exploration of lymph nodes

3.1

63.8

278

770

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

7.4

63.8

113

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

4.7

63.7

156

287

G04BD11

ATC

fesoterodine; oral

2.3

63.6

517

1962

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

4.8

63.6

150

267

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

63.5

6406

44969

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

63.5

251

655

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.8

63.4

200

448

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

6.0

63.4

119

171

XX2RW, ,

NOMESCO Finland

2.9

63.4

312

927

TPH04, ,

SPAT

3.3

63.4

249

647

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

12.1

63.2

WX199

NOMESCO Finland

Other local analgesia

2.0

63.2

698

2990

GD6AD

NOMESCO Finland

CT of chest and neck

5.1

63.2

140

236

L88

ICPC

Rheumatoid/seropositive arthritis

2.0

63.1

681

2892

ZXF00

NOMESCO Finland

Interruption caused by intraoperative deterioration of general condition

5.4

63.0

130

205

C02AC05

ATC

moxonidine; oral

1.9

63.0

865

3993

XX7LT

NOMESCO Finland

Lutetium-177-PSMA treatment

23.0

63.0

K10.25

ICD-10 Finland

Sequences of jawbones

5.7

63.0

124

187

C08CA13

ATC

lercanidipine; oral

1.4

63.0

2766

17032

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.9

62.9

306

903

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.8

62.9

340

1063

K28

ICPC

Limited function/disability (K)

2.4

62.9

453

1631

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

4.9

62.9

144

250

M48.5

ICD-10 Finland

Collapsed vertebra, not elsewhere classified

7.9

62.8

100

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.2

62.8

541

2104

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.3

62.8

513

1952

M01AE11

ATC

tiaprofenic acid; oral, rectal

2.0

62.7

672

2846

S01

ICPC

Pain/tenderness of skin

1.9

62.7

810

3664

I20.00

ICD-10 Finland

Unstable angina

2.2

62.7

564

2233

L16

ICPC

Ankle symptom/complaint

1.6

62.6

1822

10311

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.9

62.5

299

874

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

6.4

62.4

110

148

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

4.3

62.4

170

341

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.4

62.4

231

578

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

5.0

62.3

141

242

H25.8

ICD-10 Finland

Other senile cataract

1.5

62.3

2275

13512

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

62.2

4984

33858

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

4.5

62.2

159

303

L02BG03

ATC

anastrozole; oral

2.7

62.2

355

1142

A07DA03

ATC

loperamide; oral

2.1

62.2

596

2420

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

3.1

62.2

274

764

M35.7

ICD-10 Finland

Hypermobility syndrome

4.2

62.1

176

364

R28

ICPC

Limited function/disability (R)

3.0

62.1

281

796

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.8

62.0

196

440

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

8.6

61.9

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

61.9

2085

12181

S32.5

ICD-10 Finland

Fracture of pubis

3.9

61.9

193

429

R96

ICPC

Asthma

1.6

61.8

1608

8866

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.6

61.8

384

1289

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2410

8987

2.45

318.76

1.5

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

1619

4985

2.91

312.35

4.7

4.0

1.36

1.45

mmol/l

2.38

1579

4885

(3009261) Glucose [Presence] in Urine by Test strip

12808

84151

1.70

308.33

6.1

3.6

0.65

0.43

estimate

0.20

3159

16394

(3013650) Neutrophils [#/volume] in Blood by Automated count

17299

86071

4.14

307.65

22.3

8.3

4.46

4.13

e9/l

41.15

15918

73559

(3018095) Leukocytes [#/volume] in Urine

11060

57967

2.24

307.65

5.7

3.6

138.12

112.06

e6/l

1.28

8876

40481

(3024561) Albumin [Mass/volume] in Serum or Plasma

16149

69979

4.47

307.65

10.3

4.2

32.59

35.67

g/l

307.65

15450

64929

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6452

22288

3.07

307.65

3.1

2.5

19.59

23.16

60.89

6021

20557

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

7104

16261

5.00

307.65

6.0

4.1

50.02

19.89

ug/l

5.98

6336

13066

(3004809) Band form neutrophils/Leukocytes in Blood

1185

2462

4.29

307.65

3.6

3.5

1.65

1.56

0.33

1092

2172

(3017143) Hepatitis C virus Ab [Presence] in Serum

3540

13427

2.49

307.65

1.7

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1701

5258

2.91

307.65

7.4

2.7

59.28

45.17

mg/l

0.74

1447

4479

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1061

2184

4.31

307.65

2.7

2.5

9212.52

7917.15

u/ml

0.05

145

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

20511

153799

2.64

307.65

46.6

13.0

32.53

25.81

mg/l

158.15

19902

122669

(3002030) Lymphocytes/Leukocytes in Blood

14229

72321

2.86

307.65

9.2

5.9

23.02

27.57

307.65

13753

68151

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2859

5358

5.08

307.65

5.2

3.1

2244.88

1388.15

u/ml

0.68

2566

4593

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2952

9864

2.79

307.65

9.8

9.3

1.43

1.30

8.58

2930

9786

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3486

9679

3.46

307.65

5.0

3.3

5.23

5.12

kpa

9.67

3316

9184

(3001604) Monocytes [#/volume] in Blood

14910

76595

2.98

307.65

8.8

5.7

0.63

0.59

e9/l

44.56

13242

64856

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1155

2575

3.99

307.65

1.6

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

3575

13257

2.55

307.65

4.4

2.9

4.55

4.49

kpa

0.78

3452

12927

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

19640

121933

4.03

307.65

21.9

6.8

102.86

78.20

u/l

230.38

19198

114834

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

880

1716

4.52

307.65

1.2

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2887

9281

2.90

307.65

8.1

7.9

25.24

24.68

mmol/l

10.94

2866

9198

(3028308) Erythrocytes [#/volume] in Pleural fluid

865

1662

4.59

307.65

1.5

1.4

60619.27

52340.69

e6/l

0.29

504

957

(3042936) Bacteria identified in Isolate by Culture

7194

18560

4.40

307.65

2.9

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6445

17814

3.94

307.65

2.4

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2370

5554

3.96

307.65

2.7

1.8

—

(3023520) Reticulocytes [#/volume] in Blood

4049

14064

2.78

307.65

3.3

2.5

70.83

67.53

e9/l

5.90

3167

10499

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

15514

70613

3.85

307.65

11.6

5.8

1.21

mmol/l

16.92

14793

64452

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

16444

114746

1.84

307.65

6.2

3.9

20.50

11.93

mm/h

307.65

15411

106126

(3033658) Prothrombin time (PT) actual/Normal

8688

37546

2.60

307.65

7.3

3.5

87.21

87.73

1.11

8546

36701

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

9660

34113

3.49

307.65

4.2

2.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

17678

100791

3.36

307.65

7.7

4.2

1621.41

1697.51

e6/l

0.06

314

1676

(3016502) Oxygen saturation in Arterial blood

4884

15792

3.10

307.65

8.4

7.7

95.27

95.56

1.94

4719

15225

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1362

2764

4.42

307.65

6.4

4.9

752.60

1177.39

iu/ml

0.47

232

397

(3023183) Ammonium ion [Moles/volume] in Plasma

1393

3023

4.13

307.65

2.8

2.3

35.31

32.83

umol/l

1.90

1249

2695

(3026493) Urate [Moles/volume] in Serum or Plasma

7225

40054

1.80

307.65

4.3

2.6

347.52

347.85

umol/l

0.08

6347

35114

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

794

1345

5.19

307.65

2.0

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1144

2591

3.92

307.65

1.6

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

753

1257

5.26

307.65

2.0

1.7

—

(3025159) Blasts/Leukocytes in Blood

3261

13567

2.23

307.65

5.2

4.4

0.23

0.34

0.65

1599

3175

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2602

8134

2.96

307.65

5.2

3.6

24.45

24.17

mmol/l

3.57

2568

8023

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1573

4649

3.03

307.65

7.0

2.7

10.70

6.36

ratio

0.63

1033

2678

(3019225) pH of Specimen

3878

15259

2.42

307.65

8.0

3.6

7.37

7.36

3.55

3285

10298

(3001122) Ferritin [Mass/volume] in Serum or Plasma

11346

68274

1.85

307.65

4.0

2.8

245.83

139.13

ug/l

63.41

10508

63162

(3027945) Reticulocytes/Erythrocytes in Blood

5148

18210

2.84

307.65

3.2

2.4

1.90

1.73

20.86

4599

16143

(3019198) Lymphocytes [#/volume] in Blood

15104

78351

2.98

307.65

9.0

5.8

1.67

1.92

e9/l

31.24

13634

67906

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5442

17714

3.15

307.65

8.2

7.4

5.18

5.06

kpa

13.61

5230

17001

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2164

7153

2.75

307.65

7.4

3.2

127.94

54.55

u/ml

8.04

2116

6906

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4436

15702

2.76

307.65

5.2

3.5

5.88

5.78

kpa

7.55

4299

15360

(3012544) pH of Venous blood

4474

15967

2.74

307.65

5.1

3.6

7.38

2.37

2754

9567

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5910

16654

3.76

307.65

2.4

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

9286

43814

2.38

307.65

4.5

3.0

0.55

0.43

e6/l

4.50

7593

31673

(3020891) Body temperature

2113

7259

2.64

307.65

6.0

4.3

36.93

36.89

°c

4.47

2086

7205

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

15037

67368

3.76

307.65

4.7

2.5

—

estimate

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4253

12231

3.43

307.65

3.8

2.2

377.78

391.87

nmol/l

3.41

4006

11330

(3023368) Bacteria identified in Blood by Culture

13870

40827

5.99

307.65

7.2

3.8

—

(42870588) Differential panel, method unspecified - Blood

11401

50127

2.92

307.65

8.9

5.8

—

2.72

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11976

47770

3.45

307.65

4.7

2.3

60.10

64.66

u/l

0.41

11434

43864

(3021960) Folate [Moles/volume] in Serum or Plasma

8205

46293

1.81

307.65

2.0

1.6

19.20

20.12

nmol/l

5.63

7265

38569

(3021440) Promyelocytes/Leukocytes in Blood

3320

13536

2.29

307.65

5.0

4.2

0.15

0.10

3.52

1732

3381

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5345

13940

3.99

307.65

2.8

2.1

0.20

0.21

g/l

24.76

5031

12904

(3019977) pH of Arterial blood

5462

17690

3.17

307.65

8.2

7.4

7.42

0.06

3251

9732

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5572

27454

1.98

307.65

4.1

2.8

1.85

1.09

e6/l

0.94

3361

14779

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

8790

24019

4.50

307.65

2.6

1.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1471

3936

3.35

307.65

2.7

2.4

3.86

3.57

g/l

7.68

1429

3762

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10439

49419

2.51

307.65

4.0

2.9

1685.83

1475.82

ng/l

3.67

9415

42498

(3037121) Protein [Mass/volume] in Urine

1894

4756

3.62

307.65

4.4

3.1

335.59

602.18

mg/l

1.70

1184

2026

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5232

25022

2.03

307.65

4.3

2.9

2.86

2.36

e6/l

2.37

3015

12283

(3017181) Myelocytes/Leukocytes in Blood

3624

14065

2.43

307.65

4.9

4.2

1.15

0.92

6.18

2023

3896

(3008757) Leukocyte morphology finding [Identifier] in Blood

778

1389

4.92

307.65

3.8

3.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1333

3064

3.89

307.65

1.7

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1144

2591

3.92

307.65

1.6

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3247

7036

4.44

307.65

1.8

1.4

—

(3019069) Monocytes/Leukocytes in Blood

14196

70602

2.96

307.65

9.3

6.0

9.05

8.98

1.60

13602

65753

(3000991) Gas panel - Venous blood

3899

12603

2.99

307.65

9.7

8.5

—

(3018010) Neutrophils/Leukocytes in Blood

13988

70712

2.84

307.65

8.9

5.8

61.10

57.39

200.78

13542

67242

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1761

3440

4.66

307.65

2.0

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6193

19685

3.33

307.65

7.9

5.4

1.05

1.03

mmol/l

5.54

5853

18193

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2828

8767

3.01

307.65

9.2

9.4

24.80

24.19

mmol/l

16.74

2756

8528

(3013115) Eosinophils [#/volume] in Blood

15194

79222

2.98

307.65

9.3

5.9

0.18

0.19

e9/l

13.16

13598

68064

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

859

1660

4.56

307.65

1.8

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1002

2126

4.17

307.65

1.7

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3005

10515

2.67

307.65

4.3

2.7

9.95

10.91

g/l

18.94

2773

9732

(3002032) Base excess in Venous blood by calculation

4315

15281

2.75

307.65

5.3

3.5

2.14

1.79

mmol/l

7.02

3808

13377

(3014111) Lactate [Moles/volume] in Serum or Plasma

4216

13108

3.15

307.65

7.9

7.3

1.36

1.37

mmol/l

0.38

4129

12812

(3014007) Fractional oxyhemoglobin in Arterial blood

2987

9823

2.84

307.65

9.9

9.5

93.66

93.98

1.74

2971

9790

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

1395

1737

7.25

307.65

2.3

1.8

31.54

24.60

ug/l

1.62

1375

1695

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2519

8568

2.70

307.65

10.8

9.6

15.27

16.22

51.80

2434

8251

(3007853) Bacteria identified in Skin by Aerobe culture

5288

15460

3.52

307.65

2.6

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

910

1622

4.96

307.65

1.7

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1747

3347

4.75

307.65

1.9

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

7168

25964

3.00

307.65

3.2

2.5

10.58

13.20

umol/l

148.54

6710

24023

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1923

4925

3.56

307.65

5.6

3.5

25.20

24.83

mmol/l

4.81

1763

4478

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1127

2626

3.81

307.65

1.7

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6815

24225

3.02

307.65

3.1

2.4

2.20

2.30

g/l

33.99

6343

22257

(40768806) Pleura Pathology biopsy report

848

1580

4.73

307.65

1.6

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

17407

92078

3.75

307.65

9.1

4.4

6.98

6.78

mmol/l

25.31

17040

87090

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2869

9788

2.73

307.65

8.5

6.6

24.99

24.41

mmol/l

12.33

2756

9365

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

768

1182

5.71

307.65

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2018

5079

3.63

307.65

2.4

2.1

379.36

668.97

ug/l

4.67

1908

4815

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

17863

81014

5.35

307.65

17.7

5.4

10.77

12.25

umol/l

34.35

17422

76901

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2895

9489

2.85

307.65

10.0

9.7

0.67

0.64

2.53

2874

9426

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1404

3101

4.06

307.65

1.6

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

966

1902

4.49

307.65

1.5

1.4

2946.82

2605.20

e6/l

0.14

705

1348

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3101

8078

3.65

307.65

4.8

3.2

2.28

1.78

mmol/l

8.31

2444

5903

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6391

17858

3.88

307.65

6.1

4.3

261.57

245.46

u/l

7.81

6125

16941

(3002179) Metamyelocytes/Leukocytes in Blood

3392

13298

2.39

307.65

4.8

4.1

0.85

0.69

4.02

1884

3682

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2149

7108

2.75

307.65

1.8

1.7

1.75

1.51

g/l

19.82

1828

6068

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

3209

5763

5.39

307.65

2.3

1.9

2.31

2.26

ug/l

0.03

2864

5127

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

9442

38935

2.85

307.65

2.9

2.2

3.32

2.82

mg/l

57.34

8341

33137

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

9574

48712

2.19

307.65

2.8

2.1

197.15

221.67

u/l

1.53

9140

45719

(3027801) Oxygen [Partial pressure] in Arterial blood

5442

17709

3.15

307.65

8.2

7.4

12.14

12.41

kpa

2.93

5218

16995

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

888

1564

5.01

307.65

3.5

3.7

9.83

8.98

nmol/l

0.08

868

1523

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2190

5124

3.94

307.65

2.4

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2077

4055

4.72

307.65

1.4

1.2

—

(3032080) INR in Blood by Coagulation assay

16749

72663

4.83

307.65

18.6

14.3

1.25

1.28

inr

11.98

14528

60611

(3006315) Basophils [#/volume] in Blood

14960

76871

2.99

307.65

8.8

5.7

0.04

e9/l

11.06

13285

65076

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2125

4967

3.93

307.65

2.7

—

(3006504) Eosinophils/Leukocytes in Blood

14117

70417

2.93

307.65

9.2

5.9

2.50

2.88

63.74

13531

65548

(3028626) Oxygen [Partial pressure] in Capillary blood

1344

3585

3.34

307.65

3.6

2.8

7.91

8.01

kpa

1.47

1317

3491

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1683

3974

3.83

307.65

1.5

1.4

220.62

274.81

ug/g

18.04

1036

2271

(3000850) Epithelial cells [#/volume] in Urine

7935

34611

2.48

307.65

3.7

2.6

6.20

4.86

e6/l

6.47

7450

31370

(3003434) Protein [Mass/volume] in Pleural fluid

1067

2177

4.35

307.65

1.5

1.4

35.84

31.49

g/l

20.09

1000

1937

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4442

9626

4.67

307.65

2.0

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6827

30270

2.33

307.65

2.1

1.6

1.70

1.34

mg/l

11.62

5689

23523

(40758558) Short blood count panel - Blood

8435

46562

1.88

307.65

16.5

5.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2359

8276

2.60

307.65

2.6

1.9

1.18

1.38

g/l

2.76

2135

7594

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1320

1599

7.43

307.65

7.1

5.5

11.96

mg/l

0.00

1230

1488

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1812

5305

3.09

307.65

3.7

2.8

25.15

24.70

mmol/l

4.06

1779

5204

(3034860) Kappa light chains.free [Mass/volume] in Serum

1703

5264

2.91

307.65

7.4

2.8

95.15

71.36

mg/l

0.32

1453

4480

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3726

13134

2.71

307.65

4.0

2.1

53.00

53.31

u/l

0.01

3209

11123

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

16813

80232

4.16

307.65

13.5

6.3

1.21

mmol/l

24.14

14727

68367

(3026008) Bacteria identified in Urine by Culture

10765

46531

2.88

307.65

4.6

3.0

—

(3002582) Erythrocytes [#/volume] in Urine

10607

51215

2.46

307.65

4.8

3.1

80.86

97.00

e6/l

0.52

8837

38659

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12007

60691

2.49

307.65

6.1

3.4

54.21

72.95

ng/l

0.63

10235

43931

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5064

69944

0.51

307.65

1.9

1.58

1.30

mmol/l

61.30

4264

57747

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2210

4571

4.47

307.65

3.2

2.8

0.33

0.35

iu/ml

1.31

1271

2509

(40768441) Liver Pathology biopsy report

661

863

6.71

307.65

1.3

—

(3003396) Base excess in Arterial blood by calculation

5450

17555

3.18

307.65

8.1

7.3

1.45

0.92

mmol/l

17.37

4668

14322

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9707

50211

2.15

307.65

6.0

2.9

40.70

35.07

u/l

2.58

9292

47134

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3680

15012

2.31

307.65

5.9

3.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

2028

2988

6.28

307.65

4.8

2.9

1239.51

1085.05

u/ml

0.15

1867

2670

(3019309) Folate [Moles/volume] in Red Blood Cells

6314

27047

2.39

307.65

2.0

1.7

1209.24

1142.40

nmol/l

5.77

4970

20085

(3026782) Osmolality of Urine

7006

29763

2.47

307.65

3.9

2.8

503.36

543.43

mosm/kgh2o

48.80

6421

25955

(3020779) Urea [Moles/volume] in Serum or Plasma

4465

13579

3.26

307.65

9.4

6.6

9.79

10.50

mmol/l

7.69

4280

12934

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1313

2258

5.22

307.65

1.9

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

12331

53634

3.14

307.65

8.5

3.0

2.34

2.36

mmol/l

27.54

11593

48073

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

979

1747

4.96

307.65

2.9

2.6

2151.04

919.71

u/ml

0.59

963

1729

(3022096) Basophils/Leukocytes in Blood

14045

70607

2.87

307.65

9.3

6.0

0.59

0.68

81.82

13470

65664

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6045

30306

1.96

307.65

5.7

3.6

192.42

614.85

ng/l

14.64

5076

24442

(4035726) Immunohistochemistry procedure

5224

13333

4.06

307.65

1.6

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4071

12750

3.11

307.65

4.9

2.4

64.98

66.38

g/l

21.30

3725

11653

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3288

12923

2.38

307.65

2.9

2.2

5.42

8.06

ug/l

11.59

2759

11406

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1751

3755

4.24

307.65

2.1

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7752

30729

2.77

307.65

6.6

2.6

2.49

2.45

mmol/l

140.16

7218

27377

(36304419) Bacteria [Presence] in Urine

8755

40919

2.36

307.65

4.5

3.0

4.58

222.60

estimate

0.66

255

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4863

16502

2.94

307.65

4.5

2.4

13.77

9.16

umol/l

15.12

4326

14499

(3012095) Magnesium [Moles/volume] in Serum or Plasma

9147

24035

4.80

307.65

5.7

2.9

0.79

0.82

mmol/l

88.17

8799

22376

(3037467) Urinalysis macro (dipstick) panel - Urine

16996

106059

2.53

307.65

7.3

4.1

2.12

70.70

0.50

195

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1310

2158

5.45

307.65

1.8

1.4

—

(3018418) pH of Serum or Plasma

10570

46733

2.76

307.65

8.0

3.7

7.40

4.19

8285

32837

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3893

16492

2.23

307.65

1.8

1.5

—

(3019060) Gas panel - Arterial blood

3138

9084

3.27

307.65

5.4

4.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4400

14711

2.94

307.65

9.1

8.2

115.75

122.24

g/l

74.16

4304

14361

(3009343) pH of Capillary blood

3404

9375

3.48

307.65

5.0

3.3

7.42

0.29

2956

7684

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6380

23416

2.86

307.65

2.7

1.9

29.91

29.58

3.58

6239

22745

(3035350) Ketones [Presence] in Urine by Test strip

12712

83430

1.70

306.38

6.0

3.6

7.82

3.09

estimate

1.85

3344

17486

(3037756) Immunofixation for Serum or Plasma

1208

3165

3.39

305.23

2.6

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

7993

46315

1.74

304.77

6.3

3.7

0.00

estimate

0.51

2918

15300

(44790049) Parainfluenza type 3 nucleic acid detection

820

1629

4.43

304.77

1.8

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

820

1629

4.43

304.77

1.8

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

820

1629

4.43

304.77

1.8

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

820

1629

4.43

304.77

1.8

1.4

—

(1616796) Gas panel - Central venous blood

1216

3223

3.35

301.67

4.5

3.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

12558

82373

1.69

300.88

6.0

3.6

0.00

estimate

1.23

3246

17009

(46235355) HIV 1 and 2 tests - Meaningful Use set

3990

18763

1.99

295.34

1.8

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1346

3871

3.10

292.06

1.6

1.2

—

(3021589) Normoblasts [#/volume] in Blood

10966

69752

1.67

291.73

22.9

10.3

0.01

0.00

e9/l

0.92

9059

56883

(1761868) Lipid panel - Serum or Plasma

4504

61284

0.53

291.24

3.2

3.4

—

(40768797) Stomach Pathology biopsy report

4201

20302

1.95

286.45

1.4

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

609

998

5.33

282.91

1.7

1.5

—

(3015736) pH of Urine

10381

65525

1.66

280.48

5.2

3.2

6.31

6.22

13.67

5958

36355

(3017354) Segmented neutrophils/Leukocytes in Blood

770

1570

4.30

276.73

3.6

3.4

59.94

55.65

5.10

686

1335

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2745

11480

2.19

275.98

4.4

3.7

103.28

91.08

ng/l

5.30

2348

9784

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

647

1148

4.93

275.07

2.0

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

647

1148

4.93

275.07

2.0

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

647

1148

4.93

275.07

2.0

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2890

12431

2.13

270.23

3.5

2.8

217.14

229.06

ng/l

0.65

2675

11454

(3045788) Cell count panel - Pleural fluid

751

1530

4.31

270.14

1.5

1.4

—

(3012501) Base excess in Blood by calculation

1089

2892

3.33

268.84

5.3

3.8

2.91

2.53

mmol/l

3.78

811

1971

(3000494) Fungus identified in Specimen by Culture

3773

17926

1.96

268.60

1.8

1.4

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1089

2894

3.33

268.54

5.3

3.8

5.04

4.99

kpa

1.24

1066

2817

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2964

12909

2.11

268.20

7.5

3.3

1.22

1.23

mmol/l

9.41

2796

10888

(3027315) Oxygen [Partial pressure] in Blood

1093

2914

3.32

268.15

5.3

3.9

8.44

8.50

kpa

0.54

1070

2836

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6116

33842

1.75

266.93

1.9

1.7

21860184.02

35197942.07

pmol/l

1.20

5119

27644

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1223

3508

3.09

266.08

1.8

1.6

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

718

1429

4.40

265.97

6.5

3.4

110.41

44.16

u/ml

4.33

702

1412

(3021901) Oxygen saturation in Capillary blood

1149

3187

3.19

264.36

3.6

2.8

89.12

89.61

1.30

1121

3098

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

943

2323

3.58

261.13

7.0

3.0

95.11

32.81

u/ml

8.49

925

2243

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1306

3947

2.94

259.36

2.6

2.1

91.60

90.71

0.62

1283

3773

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

656

1238

4.63

259.34

3.7

2.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

11195

72923

1.62

259.05

2.5

2.1

90.97

96.10

pmol/l

24.61

6913

38127

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2137

8303

2.33

255.19

4.1

2.6

1.37

1.17

14.03

2123

8264

(3004119) Hemoglobin [Mass/volume] in Venous blood

2477

10264

2.19

253.55

4.4

3.0

120.21

130.48

g/l

83.81

2393

10017

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2177

8563

2.30

252.55

5.4

3.8

48.84

46.00

5.66

2149

8456

(3036782) Glucose [Moles/volume] in Pleural fluid

720

1501

4.20

251.30

1.3

6.04

6.41

mmol/l

2.43

675

1404

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2117

8255

2.32

250.50

4.0

2.6

0.65

0.63

2.75

2107

8228

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1229

3671

2.97

248.99

1.2

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

1079

2997

3.18

247.43

3.3

2.5

15.12

16.59

38.69

1063

2922

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

713

1494

4.18

247.19

1.3

429.96

516.47

u/l

0.62

688

1411

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

766

1695

3.96

246.95

1.7

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

767

1703

3.95

246.12

1.7

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

775

1737

3.91

245.50

1.7

1.3

—

(3003181) Sodium [Moles/volume] in Urine

1024

2772

3.26

244.85

1.5

1.3

59.35

62.35

mmol/l

1.36

781

2218

(3042631) Mycobacterium sp identified in Specimen

823

1930

3.74

244.67

2.3

2.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

739

1612

4.02

242.88

1.7

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

738

1611

4.01

242.31

1.7

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

737

1608

4.02

242.15

1.7

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2018

7847

2.32

239.89

4.9

3.2

25.38

25.26

mmol/l

0.79

1943

7641

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

14421

100984

1.62

238.18

5.5

3.0

91.10

47.12

u/l

150.21

13611

93735

(3047181) Lactate [Moles/volume] in Blood

1374

4470

2.73

237.69

7.4

5.5

1.33

1.36

mmol/l

0.38

1224

3959

(3025941) Bacteria identified in Stool by Culture

1858

7003

2.38

237.00

1.4

1.2

—

(3010421) pH of Blood

1410

4681

2.68

234.46

5.2

3.3

7.41

2.06

1387

4608

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1641

5910

2.48

230.98

4.8

2.1

3.06

2.85

g/l

10.06

1474

5295

(3043409) Potassium [Moles/volume] in Arterial blood

1306

4207

2.76

230.07

5.0

4.4

3.91

3.89

mmol/l

0.53

1292

4164

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1726

6376

2.42

229.94

4.7

2.0

4.19

4.22

g/l

0.54

1560

5770

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1727

6386

2.42

229.56

4.7

2.0

7.79

7.27

g/l

22.66

1560

5771

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1723

6365

2.42

229.52

4.7

2.0

3.65

3.74

g/l

1.02

1558

5757

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1512

5307

2.54

224.48

4.9

2.2

1.39

0.89

g/l

3.34

1254

4506

(3003694) ABO and Rh group [Type] in Blood

7142

42795

1.63

222.28

1.5

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1006

2868

3.09

220.49

1.4

13.46

11.07

u/l

4.19

814

2294

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1167

3628

2.84

219.50

3.0

2.4

224.89

195.02

19.09

1129

3429

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

10717

70895

1.56

216.94

2.9

2.3

76.10

1372.76

nmol/l

0.50

9686

63377

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

490

843

5.06

215.54

1.5

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

582

1160

4.38

214.95

1.3

12.38

13.59

u/l

0.83

542

1061

(3052851) Hemolysis interference index of Serum or Plasma

1164

3668

2.81

213.41

4.7

3.2

2.22

2.10

index

0.27

737

1768

(3036489) Thrombin time

1433

5031

2.53

212.33

2.5

1.9

21.53

21.11

1.44

1307

4465

(3000475) Leukocytes [#/volume] in Synovial fluid

1018

3000

2.99

210.62

1.8

1.5

20293.39

12412.40

e6/l

3.22

781

2175

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

479

826

5.04

210.14

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

392

582

5.84

201.68

1.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

392

582

5.84

201.68

1.6

1.3

—

(3011412) CD3 cells [#/volume] in Blood

577

1224

4.11

196.59

2.3

2.4

1149.55

1119.19

e6/l

0.29

521

1102

(3028271) Lactate [Moles/volume] in Capillary blood

806

2164

3.26

194.79

2.3

1.8

1.71

1.75

mmol/l

0.52

789

2095

(3042111) Morphology [Interpretation] in Bone marrow Narrative

895

2572

3.06

193.20

2.1

1.6

—

(3017732) Neutrophils [#/volume] in Blood

3658

18933

1.78

192.53

5.1

3.0

5.26

4.50

e9/l

3.07

3076

16097

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

525

1060

4.31

190.68

1.7

1.4

—

(3014271) Vancomycin [Susceptibility]

401

644

5.40

190.16

3.6

2.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

20585

161786

2.07

189.45

49.2

16.4

138.56

139.83

mmol/l

307.65

20352

157975

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

415

693

5.20

188.65

2.2

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

415

693

5.20

188.65

2.2

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

415

693

5.20

188.65

2.2

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

414

693

5.18

187.69

2.2

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1591

6184

2.29

187.66

1.5

1.6

10.80

17.21

iu/ml

0.75

175

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1459

5465

2.37

187.33

4.7

2.0

9.69

10.38

g/l

5.09

1273

4802

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

876

2549

3.02

184.99

1.5

1.4

26.94

24.26

u/ml

0.15

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

879

2577

2.99

183.20

1.6

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

339

480

6.11

182.79

2.4

1.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

20587

162143

2.04

182.21

49.6

16.6

4.00

3.98

mmol/l

32.14

20352

158064

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

336

476

6.11

181.08

2.4

1.9

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

523

1097

4.15

180.81

1.5

1.4

12.42

13.05

u/l

1.00

501

1057

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

336

477

6.10

180.71

2.4

1.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1057

3459

2.69

179.83

1.6

1.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1393

5204

2.37

179.73

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

298

378

6.81

178.12

2.1

1.5

90.84

114.35

umol/l

0.77

156

163

(21494890) Protein electrophoresis panel - 24 hour Urine

626

1521

3.59

176.36

3.3

1.8

—

(3013512) EKG study

9023

59226

1.51

176.27

5.2

3.5

0.88

0.71

1.52

144

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1827

7704

2.12

175.89

6.8

4.4

1.72

1.57

7.01

1728

7336

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

9456

62731

1.50

175.05

6.2

3.6

0.63

0.69

estimate

0.06

2752

13677

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1213

4334

2.47

172.39

3.5

2.8

1.71

1.57

mg/l

5.15

1123

3904

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

536

1189

3.92

171.88

2.4

1.6

4.28

3.92

mg/l

0.80

518

1138

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

610

1482

3.59

171.86

1.3

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1087

3710

2.58

169.93

2.8

2.1

120.07

131.31

g/l

34.78

827

2876

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

622

15154

0.33

169.69

1.7

2.1

3.62

3.47

ratio

1.72

524

11955

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

506

1089

4.04

169.04

1.4

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

629

1601

3.43

165.16

2.2

1.7

88.72

89.47

1.89

624

1575

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

779

2289

2.98

161.52

1.5

1.4

148.37

150.18

au/ml

0.14

215

695

(3020876) Protein [Mass/time] in 24 hour Urine

684

1862

3.21

161.41

3.1

2.3

1.04

1.20

g/24h

0.84

445

1083

(3007930) Methemoglobin/Hemoglobin.total in Blood

1674

7055

2.11

160.87

7.2

4.6

0.86

0.87

0.75

1578

6696

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2744

13730

1.81

159.25

3.4

2.4

0.57

0.41

e6/l

2.68

2662

13153

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2515

12260

1.85

158.84

4.9

2.5

61.34

64.62

ml/min/173m2

3.63

1209

5011

(3037522) Nuclear Ab [Titer] in Serum

3561

19213

1.69

158.55

1.4

1.3

499.83

521.07

titre

0.31

819

4201

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1200

4443

2.38

157.50

4.5

2.1

0.06

0.03

g/l

1.06

1065

3970

(3007164) IgA [Mass/volume] in Serum or Plasma

4680

27125

1.60

156.83

2.2

1.4

2.62

2.51

g/l

1.32

3144

16254

(3011397) Hemoglobin [Presence] in Urine by Test strip

6031

37124

1.53

154.69

5.5

3.5

0.32

0.23

0.26

474

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

356

11076

0.26

152.88

1.6

1.8

3.49

mmol/l

0.01

257

7800

(3035880) pH of Pleural fluid

418

840

4.31

152.66

1.3

7.40

0.10

309

596

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

423

879

4.17

147.98

2.5

2.6

0.62

0.63

e9/l

0.11

396

842

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

434

929

4.05

146.00

2.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1135

4265

2.34

143.83

4.6

2.1

0.00

g/l

0.07

972

3716

(3039000) Anion gap in Blood by calculation

918

3132

2.57

143.27

9.1

6.3

11.01

11.30

mmol/l

1.78

831

2824

(3018572) Chloride [Moles/volume] in Blood

918

3133

2.57

143.18

9.1

6.3

104.80

105.16

mmol/l

1.44

831

2825

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11756

83328

1.43

142.65

3.2

2.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

396

806

4.26

142.29

1.8

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

387

777

4.31

141.50

1.8

1.4

—

(3010503) CD19 cells [#/volume] in Blood

394

804

4.24

141.10

2.4

2.6

218.43

492.90

e6/l

1.04

377

783

(3023419) Bacteria identified in Sputum by Culture

640

1823

3.06

139.90

2.5

2.4

—

(3047189) Immunofixation for 24 hour Urine

343

632

4.69

139.33

2.5

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

16754

156503

0.66

138.04

4.9

5.2

1.37

1.47

mmol/l

166.52

14990

144544

(3045142) Bone marrow Pathology biopsy report

629

1791

3.06

137.58

1.5

1.3

—

(1175426) CD3 cells/Lymphocytes in Blood

439

991

3.84

137.36

2.0

73.15

71.47

1.12

415

954

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

424

938

3.92

136.42

1.9

2.0

15.20

16.25

0.97

410

914

(3045414) Leukocytes [Presence] in Urine

2836

14951

1.71

135.68

2.8

1.9

0.02

estimate

0.01

465

3084

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

395

841

4.07

133.83

2.6

221.79

245.31

e6/l

1.11

349

731

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

332

618

4.64

133.24

2.4

2.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

305

529

4.98

132.89

1.9

1.8

2327.77

2998.87

e6/l

0.13

208

359

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

414

919

3.90

132.58

1.8

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

386

815

4.10

132.24

2.5

557.67

512.63

e6/l

0.76

319

673

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

769

2508

2.68

131.22

1.3

1.2

24.59

45.33

u/ml

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1065

4088

2.29

128.23

1.5

18.47

15.17

iu/ml

0.18

(3045424) Erythrocytes [Presence] in Urine

1646

7495

1.95

126.70

2.8

2.0

0.68

0.13

estimate

0.41

399

2249

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

16953

157493

0.67

126.65

4.9

5.3

4.42

4.62

mmol/l

106.69

15257

146335

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

418

968

3.74

126.16

4.1

3.9

248.69

157.67

nmol/l

1.66

409

958

(21494815) CD4 cells/Lymphocytes in Specimen

465

1162

3.47

125.48

2.1

37.55

37.66

0.05

451

1146

(3006571) Granulocytes/Leukocytes in Synovial fluid

535

1462

3.18

125.33

1.8

1.5

64.07

58.38

2.65

386

906

(40761536) Microorganisms panel - Urine sediment

2322

11821

1.76

125.14

6.4

3.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

272

454

5.17

123.72

2.1

1.7

21242.22

25906.71

u/ml

0.08

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

342

695

4.25

123.14

3.3

3.5

1.68

1.21

3.69

342

695

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

532

1465

3.15

123.05

1.5

1.3

30.04

32.40

u/l

0.76

472

1184

(21494755) Public health laboratory ask at order entry panel

534

12036

0.36

121.23

1.2

1.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

191

227

7.24

120.93

6.1

5.8

44.72

69.36

u/l

0.81

191

221

(3037692) Legionella sp identified in Specimen by Organism specific culture

267

449

5.13

120.45

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

273

471

5.00

119.68

2.0

1.6

2.03

1.96

umol/l

0.52

254

424

(3019150) Specific gravity of Urine by Refractometry

5712

36298

1.46

119.27

6.4

3.8

1.02

1.06

kg/l

0.48

4262

23819

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1027

4004

2.25

119.04

4.8

2.1

0.00

g/l

-0.00

968

3714

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1027

4011

2.25

118.54

1.7

1.6

0.24

0.23

g/l

3.26

974

3815

(3000012) Reticulocyte production index

717

2382

2.62

117.88

2.4

2.1

0.89

0.90

0.28

581

1609

(4281824) Cell count and differential, peritoneal fluid

549

1581

3.02

117.70

1.3

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

922

3462

2.33

116.67

1.3

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

262

446

5.07

116.61

1.7

12780.04

8882.70

e6/l

0.37

138

227

(3032057) Clostridioides difficile [Presence] in Stool

190

235

6.96

116.20

2.0

1.7

—

(3008295) Osmolality of Serum or Plasma

544

1573

3.00

115.80

1.4

275.73

278.21

mosm/kgh2o

1.62

436

1205

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

703

2334

2.62

115.71

1.3

1.2

295.27

271.01

u/ml

1.14

456

1449

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

360

798

3.90

115.52

2.8

2.9

37.60

37.13

0.14

224

419

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1041

4151

2.20

114.17

1.7

1.6

1.22

1.17

g/l

4.23

988

3963

(40768795) Lymph node Pathology biopsy report

539

1568

2.99

113.53

1.3

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

259

448

4.99

113.23

1.3

3.31

3.60

mmol/l

0.69

243

412

(3002256) Pathology report gross observation

3708

21757

1.55

113.05

1.4

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

671

2225

2.63

110.69

1.6

0.65

0.88

g/l

5.89

503

1717

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

782

2792

2.44

110.64

1.3

106.15

110.00

titre

0.03

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

779

2778

2.45

110.50

1.3

108.59

301.36

titre

4.99

217

(3024891) Influenza virus A+B Ag [Presence] in Specimen

831

3052

2.38

110.49

1.4

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

17394

160027

0.68

109.73

5.4

6.0

2.53

2.69

mmol/l

98.18

15590

148174

(3044927) Protein electrophoresis panel - Urine

505

1453

3.02

108.42

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

272

512

4.58

107.74

2.1

1.5

28.00

29.86

umol/l

1.80

263

471

(3024928) Oxygen saturation in Venous blood

930

3629

2.24

107.42

3.7

2.8

60.24

61.66

0.98

892

3493

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

487

1392

3.03

105.75

3.7

3.8

—

(3044007) Cell count panel - Peritoneal fluid

250

446

4.83

105.52

1.8

1.9

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

454

1257

3.13

104.05

2.9

2.3

915.74

907.29

0.03

449

1246

(3021162) Amylase [Enzymatic activity/volume] in Specimen

182

245

6.39

103.07

3.0

2.6

1271.04

1554.15

u/l

0.14

163

218

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

418

1111

3.26

102.43

1.3

1.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

145

152

8.20

101.80

8.9

8.1

0.30

0.48

umol/l

0.60

132

137

(3010144) Erythrocytes [#/volume] in Synovial fluid

430

1173

3.17

101.01

1.5

1.4

227591.58

100921.75

e6/l

1.97

312

767

(40761511) CBC panel - Blood by Automated count

19888

159309

1.59

100.16

37.0

12.5

—

5.22

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

313

703

3.84

98.66

1.3

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

238

433

4.74

98.20

3.2

2.7

0.60

0.62

mmol/l

1.35

238

433

(3014765) Yersinia sp identified in Stool by Organism specific culture

876

3468

2.21

97.59

1.3

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

353

876

3.48

96.29

2.4

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

874

3478

2.19

96.13

1.3

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

956

3951

2.12

95.53

1.2

90.56

141.14

titre

1.48

385

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

868

3460

2.19

95.05

1.3

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1757

8944

1.74

93.40

3.7

3.5

4.29

4.47

pmol/l

7.52

1566

7985

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

232

434

4.61

92.63

1.3

353.01

191.26

ug/l

0.66

155

216

(3034770) Mitochondria Ab [Titer] in Serum

937

3899

2.10

91.94

1.2

519.23

1012.27

titre

2.10

119

(3026051) Granulocytes/Leukocytes in Pleural fluid

197

325

5.22

90.84

1.5

1.3

20.27

22.05

0.33

169

260

(3026389) Candida sp identified in Specimen by Organism specific culture

567

1913

2.57

90.26

1.4

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

429

1259

2.95

88.97

2.6

2.4

27.09

22.56

iu/ml

0.36

157

(3022145) Colonoscopy Study observation

3017

17803

1.52

87.39

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

399

1138

3.03

86.98

4.9

2.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

639

2321

2.39

86.95

1.1

—

(21494434) Karyotype in Bone marrow

453

1389

2.82

86.80

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

415

1218

2.95

86.06

1.3

1.2

—

(4062490) Immunoglobulin typing, IgG

438

1328

2.85

85.68

1.6

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

530

1778

2.58

85.35

10.2

7.75

7.42

mmol/l

0.60

453

1470

(3041096) Erythrocytes [Presence] in Urine by Automated

6503

44269

1.36

85.17

5.5

3.2

0.55

0.30

estimate

0.58

2680

13065

(3028192) IgG subclass 2 [Mass/volume] in Serum

443

1358

2.82

84.93

1.5

1.4

2.61

3.12

g/l

6.54

315

976

(3024139) IgG subclass 3 [Mass/volume] in Serum

442

1357

2.82

84.50

1.5

1.4

0.38

0.44

g/l

1.88

315

973

(3016228) CD19 cells/cells in Blood

248

527

4.06

84.33

1.8

2.0

8.36

8.25

0.04

240

516

(3028433) Virus identified in Specimen by Culture

208

385

4.65

84.14

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

441

1360

2.81

83.61

1.5

1.4

6.37

6.99

g/l

2.40

314

974

(3016650) Hepatitis A virus Ab [Presence] in Serum

618

2256

2.38

83.15

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

279

659

3.65

81.93

1.5

1.2

219.58

407.32

u/l

1.79

269

610

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

289

702

3.55

81.45

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

259

583

3.83

81.45

1.2

1.1

3.57

3.10

iu/ml

0.24

(3027456) Digoxin [Moles/volume] in Serum or Plasma

796

3258

2.13

81.43

3.6

3.2

0.82

0.80

nmol/l

0.56

603

2611

(3049717) Cytology report of Urine Cyto stain

1337

6534

1.80

81.43

2.6

2.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

187

327

4.92

80.84

1.4

1.2

41.29

39.60

g/l

0.63

177

(3020564) Creatinine [Moles/volume] in Serum or Plasma

20605

167689

1.62

80.42

54.9

18.3

83.46

79.59

umol/l

22.92

20395

165253

(3005532) Lymphocytes/Leukocytes in Pleural fluid

246

539

3.93

80.29

1.4

62.27

63.59

0.21

204

436

(3017704) Immunofixation for Urine

312

811

3.32

79.27

2.8

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

152

225

5.81

78.56

1.3

1.2

2908.82

406219.55

u/ml

0.50

(3003129) Base excess in Capillary blood by calculation

524

1820

2.50

78.53

2.8

2.1

0.90

0.51

mmol/l

1.28

504

1738

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

745

3018

2.15

78.23

1.6

1.4

352.51

149.88

pmol/l

7.11

725

2947

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

475

1576

2.61

78.22

1.3

1.2

97.10

55.98

u/l

4.55

445

1372

(3000093) Morphology [Interpretation] in Blood Narrative

455

1480

2.66

77.93

1.2

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

215

436

4.25

77.73

1.8

2.0

1.80

1.75

ratio

0.14

206

424

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3184

19415

1.47

77.67

13.9

6.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

321

866

3.20

76.84

2.5

1.8

7.84

8.48

mmol/l

2.08

321

866

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

116

132

7.54

76.28

2.9

3.2

1.17

1.27

mg/l

0.18

(3002331) Protein [Mass/volume] in Peritoneal fluid

183

332

4.74

75.84

1.3

36.86

25.51

g/l

0.92

153

261

(3017569) Oxygen content in Arterial blood

319

870

3.16

75.02

2.6

2.1

14.83

16.13

8.67

319

870

(3008536) Aspergillus sp Ab [Presence] in Serum

164

275

5.13

74.35

2.6

2.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

205

416

4.24

74.07

1.4

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

101

4397

0.19

73.23

1.1

0.61

0.62

ratio

0.17

673

(3016038) Potassium [Moles/volume] in Urine

340

988

2.97

71.80

1.3

1.1

34.55

34.70

mmol/l

0.04

294

867

(3004451) EKG impression Narrative

302

827

3.15

70.57

1.4

1.2

—

(3045716) Anion gap in Serum or Plasma by calculation

464

1612

2.49

69.52

3.6

2.9

10.15

10.85

mmol/l

3.69

456

1593

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

608

2380

2.22

69.50

1.3

1.6

8.35

11.34

u/ml

—

(40757494) Bilirubin.total [Moles/volume] in Blood

269

695

3.34

69.05

2.6

2.1

40.32

17.68

umol/l

0.81

(3051611) Lipemic interference index of Serum or Plasma

428

1439

2.57

68.64

4.9

3.2

13.34

12.84

index

0.41

336

704

(3023420) DNA double strand Ab [Units/volume] in Serum

1155

5682

1.78

68.54

1.8

1.7

8.98

7.35

iu/ml

0.71

290

1420

(3001964) Herpes simplex virus Ag [Presence] in Specimen

166

304

4.69

68.08

1.6

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2569

15388

1.48

67.85

2.0

1.7

1.64

1.49

15.15

2162

13452

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

832

3711

1.95

67.18

1.5

1.3

637.77

539.49

mg/l

1.30

795

3565

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

20327

165778

1.51

67.11

27.3

10.7

26.27

26.00

u/l

0.89

19954

159831

(3026692) Albumin [Mass/volume] in Peritoneal fluid

192

400

4.13

67.10

1.3

1.2

14.86

13.34

g/l

1.33

157

305

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

518

1936

2.32

66.07

1.1

1.70

1.50

g/l

14.95

474

1768

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

899

4140

1.89

65.98

1.6

1.5

17.36

8.84

iu/ml

0.30

186

819

(3043410) Blood group antigens tested for on Red Blood Cells

182

369

4.24

65.89

2.6

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

180

363

4.26

65.61

3.1

3.2

1.53

1.92

ratio

1.95

164

337

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

200

440

3.91

65.00

2.1

2.0

33.93

29.36

2.70

188

416

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

493

1818

2.35

64.84

2.3

1.9

29.80

27.96

mg/l

0.29

194

634

(3013727) Leukocytes other/Leukocytes in Blood

207

469

3.80

64.59

3.8

3.7

57.92

51.66

3.04

207

447

(3048689) Calprotectin [Mass/mass] in Stool

2786

17103

1.45

64.58

2.4

2.2

218.85

133.14

ug/g

14.92

2244

13295

(3001893) Eosinophils/Leukocytes in Pleural fluid

206

467

3.80

64.23

1.4

2.73

2.50

0.13

176

390

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3565

22919

1.39

63.61

1.3

13.04

12.94

u/ml

0.03

1331

8820

(3048879) Bone marrow aspiration report

192

417

3.96

63.51

2.0

1.7

2.00

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3821

24873

1.38

63.16

1.4

1.3

37.62

39.18

iu/ml

0.20

1142

7733

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2271

13452

1.49

63.10

2.6

2.2

8.71

13.67

nmol/l

118.00

1920

12197

(40758292) HTLV I+II Ab panel - Serum

142

243

5.02

62.99

1.5

1.3

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

362

1169

2.67

62.94

1.7

1.5

21.73

31.03

5.98

253

714

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

293

844

2.99

62.88

1.2

84.59

85.42

0.08

(3044889) 12 lead EKG panel

14471

112505

1.28

62.57

5.3

3.9

0.57

2263.03

0.79

244

(3009015) Lactate [Moles/volume] in Synovial fluid

8.20

61.26

1.3

1.1

6.83

6.72

mmol/l

0.03

(3020717) Zinc [Moles/volume] in Serum or Plasma

248

658

3.25

61.08

1.9

1.3

26.22

25.85

umol/l

0.05

232

604

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

805

3668

1.91

60.98

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

112

7.28

60.68

1.1

1.0

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

188

416

3.89

60.64

1.4

17.76

20.55

0.68

168

376

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

229

582

3.39

60.37

1.7

1.3

2047833.00

1227235.48

iu/ml

0.67

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

738

3280

1.95

60.18

1.4

1.3

3.89

3.79

mmol/l

1.48

691

3130

(3052592) Norovirus Ag [Presence] in Stool

136

234

4.99

59.98

1.5

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

412

1452

2.45

59.91

1.5

1.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1948

11351

1.51

58.35

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1039

5190

1.75

58.34

1.3

1.2

0.97

0.86

u/ml

0.10

397

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

16390

149239

0.77

58.30

4.4

1.44

1.25

mmol/l

151.23

14574

136388

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

195

458

3.66

57.86

4.3

2.3

4.99

4.91

kpa

0.45

195

458

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

195

458

3.66

57.86

4.3

2.3

10.17

10.46

kpa

0.53

195

458

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

130

223

5.01

57.55

1.4

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

557

2277

2.12

57.11

3.2

2.1

2487.26

4651.43

u/l

0.91

173

853

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

134

238

4.83

57.02

3.8

2.8

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

245

679

3.11

56.21

2.3

1.9

100.95

97.29

0.70

240

646

(3020191) Ethanol [Moles/volume] in Serum or Plasma

328

1069

2.65

56.05

1.7

1.3

1.19

1.23

promille

0.18

262

846

(3006245) CD3-CD19+ cells/cells in Blood

190

450

3.63

55.71

2.1

2.0

8.78

10.42

0.75

169

415

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

155

323

4.12

54.23

2.8

2.3

1817.68

49.38

ug/l

1.30

155

323

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

110

171

5.52

54.18

1.8

1.9

—

(3026250) Tacrolimus [Mass/volume] in Blood

197

496

3.42

52.75

45.1

37.2

7.38

7.08

ug/l

0.62

176

433

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1196

6387

1.63

52.22

1.7

2.0

38.97

39.54

u/l

0.39

1050

5620

(3024471) HLA-A [Type]

170

390

3.75

52.21

1.0

—

(40762365) Oxygen content in Arterial blood by calculation

120

210

4.90

51.97

4.6

2.1

14.29

14.94

ml/dl

1.52

109

197

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

110

178

5.30

51.95

1.5

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

278

874

2.74

50.98

1.2

1.1

40.66

20.77

u/l

5.00

254

773

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

274

857

2.75

50.74

1.9

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

242

714

2.92

49.88

3.5

4.0

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

18730

151946

1.32

49.65

41.5

13.8

77.61

77.76

ml/min/173m2

0.42

17977

139935

(40765096) Chromosome analysis panel by Banding

185

466

3.41

49.53

1.2

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

277

883

2.70

49.48

1.2

1.1

101.96

80.15

u/l

3.01

254

781

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

320

1116

2.47

47.67

1.4

1.3

2.22

2.18

mmol/l

0.23

295

1045

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

698

3289

1.84

47.60

1.6

1.4

898.73

1647.73

e6/l

1.24

570

2627

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

691

3247

1.84

47.55

1.6

1.4

20.81

33.75

e6/l

0.96

536

2431

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

139

295

4.05

47.54

1.2

—

(3024932) HLA-DR beta [Type]

161

380

3.64

47.52

1.2

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

194

521

3.20

46.96

39.1

29.0

126.19

109.39

ug/l

2.89

160

439

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4560

31617

1.29

46.89

1.3

1.46

1.81

u/ml

1.32

1191

8440

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

117

219

4.58

46.88

1.4

1.2

631.92

59.78

u/l

0.90

153

(3022621) pH of Urine by Test strip

2028

12441

1.43

46.21

3.7

2.5

6.09

6.04

1.29

1489

8504

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

15094

119609

1.24

46.01

5.3

4.2

15.16

14.87

pmol/l

32.88

13781

108660

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

810

4033

1.74

45.92

1.7

2.0

12.38

11.61

mg/l

1.46

738

3769

(3041918) Cholesterol [Moles/volume] in Pleural fluid

141

311

3.89

45.80

1.3

1.2

1.78

1.53

mmol/l

1.54

104

182

(3000060) B lymphocytes [#/volume] in Blood

141

312

3.88

45.60

2.1

2.0

0.43

1.55

e9/l

0.65

152

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

270

889

2.61

45.30

1.7

1.5

8.16

6.98

u/l

0.58

222

708

(3007461) Platelets [#/volume] in Blood

20619

170215

1.44

45.28

63.4

21.0

255.50

245.13

e9/l

66.90

20294

165666

(3021387) Prolactin [Units/volume] in Serum or Plasma

677

3212

1.83

45.17

1.7

1.9

342.34

294.76

mu/l

2.28

638

2945

(3010813) Leukocytes [#/volume] in Blood

20626

170298

1.44

45.09

63.3

21.0

7.35

6.65

e9/l

142.81

20266

165040

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

139

307

3.89

45.07

1.6

0.38

0.41

ug/l

0.39

106

209

(3035941) MCH [Entitic mass]

20620

170262

1.43

44.79

63.0

20.9

30.19

30.41

49.40

20427

167863

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3102

20513

1.34

44.67

4.7

5.2

32.17

32.61

1.32

2164

13047

(40761539) Cells [Type] in Urine sediment by Light microscopy

140

313

3.84

44.65

1.4

1.2

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

20620

170277

1.43

44.60

63.1

20.9

91.91

91.29

57.94

20427

167878

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

20620

170278

1.43

44.59

64.2

21.4

37.20

40.94

246.52

20413

167795

(3026361) Erythrocytes [#/volume] in Blood

20620

170288

1.43

44.46

63.3

21.0

4.12

4.51

e12/l

307.65

20261

164997

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

102

6.47

44.42

9.0

3.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

20622

170316

1.43

44.34

63.8

21.1

122.41

136.34

g/l

307.65

20430

167955

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

306

1089

2.42

43.68

1.1

—

(40757373) Influenza virus identified in Isolate

122

253

4.14

43.05

1.5

—

(3042517) Benzodiazepines panel - Urine

9.42

42.99

2.9

4.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

318

1161

2.36

42.90

1.5

1.6

29.36

24.37

u/ml

0.68

250

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

120

247

4.17

42.76

1.5

1.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

142

5.37

42.73

2.4

1.7

—

(4198724) Urine methamphetamine measurement

139

324

3.68

41.83

3.5

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

617

2916

1.83

41.69

4.2

3.1

11.50

9.94

pmol/l

1.01

612

2916

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

600

2823

1.84

41.13

1.3

1.2

—

(44786800) Granulocytes/Leukocytes in Body fluid

174

4.78

40.92

1.4

1.3

23.14

27.82

0.58

130

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

171

4.81

40.83

1.4

74.33

73.18

0.12

140

(3042733) HLA Ab [Presence] in Serum

149

372

3.44

40.53

4.5

5.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

334

1295

2.22

39.21

1.2

1.1

1.66

2.11

iu/ml

0.34

(3006922) Hepatitis E virus Ab [Presence] in Serum

296

1092

2.33

39.05

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

236

785

2.59

38.87

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

591

2821

1.81

38.68

1.7

1.3

58.32

29.84

u/l

6.32

520

2437

(3004716) Salmonella sp identified in Stool by Organism specific culture

1024

5668

1.57

38.36

1.3

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

418

1788

2.02

38.07

1.3

—

(3002619) Bacteria identified in Specimen by Culture

128

302

3.64

37.90

1.4

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

344

5898

0.49

37.79

1.7

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

110

234

4.03

37.60

1.4

15.72

12.53

0.52

111

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

227

755

2.59

37.42

2.1

1.8

1.98

3.74

u/field

1.48

166

518

(3022493) Free Hemoglobin [Mass/volume] in Plasma

206

653

2.71

37.32

3.4

4.0

60.61

1740.32

mg/l

1.64

149

454

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

283

1049

2.32

36.96

1.6

1.8

398.17

376.74

mu/l

0.20

235

828

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

707

3605

1.70

36.78

1.3

1.2

0.98

7.75

u/ml

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

6.21

36.72

1.5

1.3

321.14

1230.05

u/l

0.82

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

257

920

2.40

36.30

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

407

1755

2.00

36.26

1.4

1.3

—

nmol/l

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

105

222

4.06

36.20

2.2

2.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

755

3943

1.66

35.89

1.6

1.9

3.87

14.35

iu/l

1.02

219

1604

(4015189) Microbial culture of sputum

137

353

3.33

35.56

2.6

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

106

229

3.97

35.52

2.1

1.9

—

(3011288) Drugs identified in Urine by Screen method Nominal

449

2018

1.92

35.50

6.1

2.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

215

715

2.58

35.47

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

354

1467

2.08

35.16

1.4

1.3

1.62

1.43

nmol/l

1.96

322

1337

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

439

1966

1.93

35.09

1.2

4.36

9.17

u/ml

0.94

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

222

758

2.52

34.72

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

324

1305

2.14

34.66

2.2

2.0

1.92

3.54

u/field

0.41

184

697

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

414

1830

1.95

34.39

1.3

1.2

3.33

3.62

u/ml

0.31

186

877

(3042010) Triglyceride [Moles/volume] in Pleural fluid

113

262

3.70

34.35

1.3

1.2

0.88

1.63

mmol/l

0.89

165

(3018851) Theophylline [Moles/volume] in Serum or Plasma

6.06

34.26

2.0

1.7

43.54

50.26

umol/l

0.89

(40763480) Human metapneumovirus Ag [Presence] in Specimen

8.75

34.12

1.8

1.2

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

114

5.34

33.93

2.1

57.19

66.72

1.10

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

244

885

2.37

33.52

1.5

1.2

117.78

90.39

u/l

1.85

223

747

(44816559) Phosphatidylethanol [Mass/volume] in Blood

925

5165

1.55

33.31

1.9

1.6

0.32

0.31

mg/l

0.07

429

2379

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

109

252

3.71

33.28

3.0

1.4

8.75

2.29

ug/l

0.96

142

(3014051) Protein [Presence] in Urine by Test strip

5894

43474

1.22

32.95

4.2

2.8

0.10

0.08

0.33

155

1416

(3023323) Follitropin [Units/volume] in Serum or Plasma

863

4757

1.57

32.89

1.5

1.4

28.41

33.28

iu/l

4.03

709

4132

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

108

5.39

32.88

2.7

2.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

363

1562

2.00

32.58

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

410

1843

1.92

32.44

1.4

1.3

0.18

0.22

nmol/l

1.73

308

1512

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

270

1041

2.23

32.22

1.2

35.00

200.00

titre

—

(3012565) Volume of 24 hour Urine

206

704

2.51

32.19

2.9

2.1

1774.40

1966.03

1.63

184

613

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

417

1890

1.90

32.19

1.3

1.2

3.12

3.95

u/ml

0.69

146

723

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

270

1043

2.23

32.07

1.2

192.78

211.03

titre

0.13

155

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

236

861

2.36

32.02

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

157

468

2.88

31.96

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

236

862

2.35

31.94

1.5

1.2

47.30

22.67

u/l

4.00

212

717

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

741

3970

1.62

31.83

1.3

4.93

5.83

u/ml

0.41

127

608

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

447

2081

1.85

31.77

1.4

1.3

2.52

2.33

nmol/l

0.03

426

2008

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

180

4.19

31.72

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

111

270

3.53

31.51

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

454

2130

1.84

31.48

1.4

1.3

0.22

0.21

nmol/l

0.08

145

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

178

4.19

31.36

1.1

—

(1002224) Polysomnography panel

419

6367

0.55

31.09

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

150

443

2.91

31.07

1.5

1.1

0.93

0.50

g/l

0.35

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

231

850

2.34

30.77

1.3

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

336

1437

2.01

30.70

2.2

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

736

3982

1.60

30.37

1.3

7.05

5.95

u/ml

0.10

397

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

134

376

3.06

30.35

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

651

3424

1.64

30.13

1.3

1.2

3.10

5.92

u/ml

0.76

250

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

774

4247

1.58

30.09

1.3

1.2

17.68

43.48

u/ml

3.16

237

(3027923) C peptide [Moles/volume] in Serum or Plasma

231

861

2.31

29.89

1.3

1.4

1.22

1.30

nmol/l

0.50

172

655

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

121

323

3.21

29.77

5.5

7.6

64.07

72.99

1.99

253

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

9.02

29.58

1.9

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

215

782

2.36

29.42

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

215

783

2.36

29.34

1.3

1.5

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

6.42

29.32

4.6

4.7

0.00

estimate

—

(3034891) Synovial lining cells/cells in Synovial fluid

182

617

2.53

28.98

1.7

1.5

5.38

2.68

1.05

133

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

200

714

2.41

28.54

1.4

6.40

6.09

u/l

0.14

171

611

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

696

3787

1.59

28.06

2.3

142.74

88.94

ug/min

1.91

413

2200

(3029634) Reagin Ab [Titer] in Serum by VDRL

368

1676

1.89

28.05

1.9

2.3

0.45

8.10

titre

2.01

(4195642) Thrombophilia screening test

377

1732

1.87

27.98

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

336

1486

1.95

27.96

1.7

1.9

765.71

3804.18

titre

—

(3008037) Lactate [Moles/volume] in Venous blood

833

4727

1.53

27.88

4.4

3.0

1.60

mmol/l

0.03

820

4634

(1001926) Buprenorphine [Presence] in Urine by Screen method

480

2378

1.74

27.78

4.8

1.8

—

(3014891) Appearance of Pleural fluid

220

3.62

27.56

1.7

1.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

166

4.08

27.56

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

179

618

2.49

27.47

3.5

1.8

39.53

40.12

g/l

0.63

179

618

(3038026) Centromere Ab [Units/volume] in Serum

269

1106

2.09

27.40

1.2

46.93

50.63

u/ml

0.06

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

248

989

2.16

27.32

1.3

38.42

57.82

titre

1.03

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

380

1764

1.86

27.32

1.1

120.87

115.07

2.25

358

1572

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

233

908

2.21

27.18

1.1

378.65

285.37

mg/l

1.71

201

805

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

117

325

3.09

27.01

1.5

1.3

—

(3024263) Appearance of Synovial fluid

180

630

2.45

26.84

1.9

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

151

4.20

26.82

1.2

0.15

0.33

u/ml

0.54

(40762814) Titanium [Mass/volume] in Blood

141

4.31

26.63

2.0

2.6

4.38

3.95

ug/l

0.17

(3005322) IgE [Units/volume] in Serum or Plasma

1357

8520

1.38

26.59

1.5

1.3

243.12

246.78

u/ml

0.04

1251

7924

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

252

1023

2.12

26.55

1.3

687.14

434.57

titre

0.33

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

205

767

2.30

26.36

1.1

—

5.95

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

300

1306

1.98

26.16

1.2

63.94

78.51

u/ml

0.29

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

239

960

2.14

25.88

1.2

1.1

51.96

45.94

mg/l

0.52

196

816

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

273

1155

2.03

25.79

1.2

110.16

108.73

pmol/l

0.07

273

1155

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

161

545

2.54

25.77

2.1

2.0

191.21

160.57

3.13

152

513

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

448

2238

1.73

25.22

1.8

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.28

25.12

1.1

1.0

0.04

0.03

u/ml

0.23

(3020393) Adenovirus Ag [Presence] in Stool

123

4.46

25.02

1.1

—

(3036603) Volume of Urine

268

1142

2.02

24.84

2.2

1.6

1927.31

1922.28

0.03

263

1107

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

408

2.75

24.73

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

121

362

2.87

24.60

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

284

1241

1.97

24.54

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

333

1537

1.86

24.43

1.2

26.96

39.02

u/ml

0.68

(3016244) Insulin [Units/volume] in Serum or Plasma

162

565

2.46

24.39

2.6

3.0

25.93

24.63

mu/l

0.17

145

525

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

126

390

2.77

24.07

2.2

2.0

65.42

44.64

u/l

0.44

119

361

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

234

3.33

23.85

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

121

370

2.80

23.66

1.1

—

(4024509) Urine culture

1172

7325

1.39

23.58

2.5

1.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

376

1823

1.78

23.52

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

215

862

2.14

23.45

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2280

0.36

23.44

1.3

1.6

981.54

1022.28

mu/l

0.11

1855

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

235

977

2.07

23.32

1.4

13.30

12.80

umol/l

0.49

225

911

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

205

3.47

23.15

1.3

1.2

102.19

143.22

ng/l

0.39

140

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

284

1269

1.92

23.02

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

176

656

2.30

22.91

2.0

2.1

4.09

3.62

ug/l

0.21

155

608

(3025577) Chromium [Mass/volume] in Blood

170

631

2.31

22.35

2.0

2.1

2.43

2.45

ug/l

0.02

124

534

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

192

751

2.20

22.30

1.5

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

182

700

2.23

22.02

1.1

1.2

1.08

1.07

ratio

0.57

155

563

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

116

362

2.75

21.87

1.1

88.49

86.09

0.31

191

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

119

4.25

21.77

1.1

—

(3011985) Renin [Units/volume] in Plasma

429

2209

1.67

21.66

1.7

1.5

66.49

55.78

mu/l

0.50

379

1975

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

113

353

2.74

21.28

1.1

1.2

88.48

84.60

0.39

188

(3028679) Herpes simplex virus Ab [Presence] in Serum

168

638

2.26

20.98

1.1

1.2

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

110

343

2.75

20.80

1.4

67.27

56.11

2.39

299

(3023511) Choriogonadotropin [Units/volume] in Urine

231

999

1.99

20.64

1.5

1.2

—

(4268621) Lupus anticoagulant assay

278

1280

1.87

20.63

2.3

2.2

—

(46236302) HLA-C [Type] by High resolution typing

6.29

20.35

1.0

—

(40760409) HLA-A [Type] by High resolution

6.29

20.35

1.0

—

(3013862) HLA-DP [Type]

6.29

20.35

1.0

—

(40760410) HLA-B [Type] by High resolution

6.29

20.35

1.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

5.37

20.31

1.2

1.1

1.19

1.00

u/field

0.99

(3000492) Spirometry study

1939

13298

1.27

20.25

1.6

1.5

—

16.26

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

288

2.89

20.08

1.5

1.3

0.20

0.43

mmol/l

1.87

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.18

20.05

1.3

1.1

1.49

1.94

iu/ml

0.77

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

4.51

19.88

2.2

2.0

25.15

12.15

1.31

(4027681) Cerebrospinal fluid IgG ratio and IgG index

172

675

2.19

19.87

1.3

1.2

0.53

0.71

ratio

1.05

103

378

(3023410) Appearance of Cerebral spinal fluid

294

1396

1.81

19.80

1.8

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

246

1104

1.91

19.77

1.1

1.0

307.78

287.37

mg/l

3.38

217

1004

(3020491) Glucose [Moles/volume] in Blood

222

963

1.98

19.70

2.1

1.8

7.32

6.94

mmol/l

0.82

151

645

(40763590) HLA-DQ beta [Type]

6.24

19.65

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.56

19.58

1.5

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

17573

144835

1.17

19.54

6.3

5.1

1.99

2.00

mu/l

0.04

16096

132421

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

113

371

2.61

19.38

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

527

2936

1.55

19.28

4.6

1.8

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

151

572

2.26

19.02

1.6

5.65

9.22

nmol/l

0.36

128

474

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

171

683

2.15

18.94

1.1

1.25

1.18

u/l

0.34

298

(3006576) Bicarbonate [Moles/volume] in Blood

142

526

2.32

18.85

6.2

6.3

25.24

25.13

mmol/l

0.10

133

475

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

103

4.24

18.83

1.5

1.3

0.89

1.02

ml/s/173m2

0.32

(3009466) Valproate [Moles/volume] in Serum or Plasma

413

2185

1.63

18.83

4.3

5.4

321.35

364.42

umol/l

7.71

354

1882

(3009508) Creatinine [Moles/volume] in Urine

7526

58688

1.14

18.63

3.7

3.3

6.96

7.53

mmol/l

24.56

6287

49138

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

214

941

1.95

18.30

1.6

2.1

16.95

16.76

nmol/l

0.12

191

889

(3000330) Specific gravity of Urine by Test strip

1336

8852

1.31

18.22

4.8

3.3

1.02

ratio

1.58

1234

8035

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

575

3306

1.50

18.19

2.2

1.5

0.97

0.82

nmol/l

3.27

483

2813

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

279

1339

1.79

18.18

1.1

94.97

95.91

0.22

269

1240

(3024869) Neuronal Ab [Presence] in Serum

268

2.85

18.02

1.1

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.25

17.97

1.7

1.5

1.21

4.33

mg/l

2.23

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.25

17.97

1.7

1.5

0.90

2.84

mg/l

1.57

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.25

17.97

1.7

1.5

0.42

1.02

mg/l

0.94

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.25

17.97

1.7

1.5

4.15

4.66

mg/l

0.13

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.25

17.97

1.7

1.5

3.09

2.79

mg/l

0.05

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.25

17.97

1.7

1.5

1.40

2.60

mg/l

0.78

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.25

17.97

1.7

1.5

1.18

2.98

mg/l

1.32

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.25

17.97

1.7

1.5

0.60

1.33

mg/l

0.85

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.25

17.97

1.7

1.5

0.67

4.12

mg/l

2.62

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

179

3.30

17.95

1.6

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

179

3.30

17.95

1.6

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

179

3.30

17.95

1.6

1.1

—

(40768446) Kidney Pathology biopsy report

137

511

2.30

17.92

1.9

1.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

175

721

2.08

17.92

1.6

12.21

9.33

ug/l

0.47

162

663

(3020911) Cortisol [Moles/time] in 24 hour Urine

116

402

2.47

17.85

1.3

1.4

401.52

340.83

nmol/24h

0.11

116

402

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.16

17.67

1.7

1.5

0.58

2.40

mg/l

1.69

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

167

680

2.11

17.65

1.5

1.2

68.05

61.16

0.40

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

196

847

1.99

17.64

1.1

3.74

9.92

nmol/l

1.11

157

(3034274) Bile acid [Moles/volume] in Serum --fasting

199

866

1.97

17.56

1.4

1.8

19.04

8.50

umol/l

1.68

148

634

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

17082

150826

0.87

17.49

7.8

6.4

41.61

39.43

mmol/mol

136.85

15682

139631

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1392

9334

1.29

17.35

1.2

106.60

140.81

u/ml

2.57

411

3524

(3006270) Folate [Moles/volume] in Blood

258

1228

1.80

17.31

1.3

1.1

337.33

348.42

nmol/l

0.34

204

996

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1333

0.29

17.26

1.3

1.5

57.89

62.13

ug/l

0.27

1086

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

143

555

2.21

17.06

2.3

2.4

49.99

52.93

umol/l

0.49

120

478

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

4.23

16.99

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

547

3158

1.49

16.99

4.5

1.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.35

16.90

1.3

1.2

0.21

0.67

iu/ml

2.25

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

138

530

2.23

16.89

1.2

1.1

11.56

5.33

u/ml

0.26

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

314

2.62

16.66

1.3

1.17

mmol/l

0.19

314

(3022475) Manganese [Moles/volume] in Blood

4.56

16.58

1.2

1.3

0.17

0.15

umol/l

1.01

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

5.39

16.55

2.4

2.1

1.94

2.21

mg/l

0.31

(3010370) Gastrin [Moles/volume] in Serum or Plasma

217

2.96

16.34

1.5

1.9

59.33

53.86

pmol/l

0.14

183

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.50

16.33

1.1

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

964

10820

0.75

16.18

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

749

4637

1.39

16.00

1.8

1.7

—

(3034426) Prothrombin time (PT)

103

356

2.48

15.99

1.2

29.70

27.88

1.49

103

356

(3001186) Copper [Moles/volume] in Serum or Plasma

331

2.54

15.96

1.4

1.2

16.82

16.19

umol/l

0.58

283

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1262

0.30

15.92

1.2

1.4

1.50

1.22

ratio

0.50

765

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1262

0.30

15.92

1.2

1.4

1.02

0.94

ratio

0.42

762

(4034850) Laboratory test

789

4932

1.38

15.91

15.6

9.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1525

16116

0.79

15.90

1.5

1.6

—

6.33

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1261

0.30

15.90

1.2

1.4

1.07

1.16

ratio

0.25

761

(3028300) Cannabinoids [Presence] in Urine

545

3193

1.47

15.76

4.6

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

351

4688

0.63

15.66

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1249

0.31

15.62

1.2

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

135

3.49

15.62

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1977

20269

0.82

15.48

1.4

1.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

166

3.20

15.40

1.1

23.52

20.04

u/l

0.62

106

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

14.83

15.37

1.7

1.2

277.53

226.50

nmol/l

—

(3020682) Albumin/Creatinine [Ratio] in Urine

7387

58058

1.13

15.37

4.3

4.1

14.97

7.37

mg/mmol

19.04

4918

35492

(3027008) Opiates [Presence] in Urine

541

3183

1.46

15.32

4.1

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

227

1080

1.80

15.32

4.0

2.4

38.14

31.38

mg/l

1.49

192

769

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

231

2.82

15.20

1.2

70.44

65.13

0.35

(3002621) Streptococcal DNAse B [Units/volume] in Serum

106

3.80

15.07

1.1

1.0

228.00

478.84

u/ml

0.59

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1089

0.27

15.02

1.3

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

373

2039

1.57

14.95

1.4

1.3

317.90

348.75

pmol/l

0.20

318

1721

(4094501) Cardiovascular stress test using bicycle ergometer

348

4608

0.64

14.94

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.89

14.93

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

123

475

2.22

14.92

1.4

1.5

15.91

15.28

pmol/l

0.22

399

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

6.08

14.82

1.3

1.1

0.88

0.94

u/field

0.14

(40768443) Skin Pathology biopsy report

1114

7407

1.30

14.81

1.3

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

108

396

2.34

14.79

1.2

1.1

10.89

12.05

pmol/l

0.19

155

(43055442) Apixaban [Mass/volume] in Serum or Plasma

230

2.79

14.77

1.8

1.6

90.85

116.81

ug/l

1.50

179

(40768793) Breast Pathology biopsy report

608

3683

1.42

14.75

1.4

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

235

2.77

14.74

1.4

1.2

85.08

80.47

0.25

(3010838) Calcium [Moles/time] in 24 hour Urine

479

2774

1.49

14.71

1.7

1.9

4.33

5.19

mmol/24h

5.94

409

2457

(3050129) First trimester maternal screen panel - Serum or Plasma

1539

0.39

14.68

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

100

356

2.41

14.62

1.5

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1057

0.27

14.58

1.3

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

147

616

2.05

14.50

1.1

1009.37

451.28

ng/l

0.47

188

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

228

2.78

14.46

1.1

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

106

3.71

14.33

2.0

1.4

1.33

1.45

umol/l

0.73

(3005033) Fetal Nuchal fold Thickness US

1043

0.28

14.25

1.3

1.4

1.31

1.26

0.24

733

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.46

14.24

4.6

4.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

179

3.01

14.22

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

104

383

2.33

14.12

1.5

1.2

136.52

131.37

nmol/l

0.11

276

(3038515) Glucose [Moles/volume] in Venous blood

664

4117

1.39

14.10

4.8

3.1

7.57

7.67

mmol/l

0.41

655

4042

(36660697) Celiac disease serology panel - Serum

1576

10996

1.24

14.07

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

123

490

2.15

13.86

1.2

—

(4211845) Urine protein measurement

164

727

1.93

13.84

4.3

3.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.28

13.53

3.0

3.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

107

410

2.24

13.28

1.3

1.2

117.27

111.71

0.95

372

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

269

2.55

13.23

1.3

1.1

89.07

29.69

mg/l

0.42

193

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

806

5207

1.33

13.20

1.5

1.6

24.26

20.52

u/ml

0.62

140

1244

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

369

2.30

13.12

1.2

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.85

13.11

1.1

1.0

—

(3007463) Buprenorphine [Presence] in Urine

14.48

12.99

6.8

12.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

404

5036

0.68

12.92

1.9

1.7

10.48

3.72

mg/l

7.42

358

3613

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

144

3.15

12.92

1.9

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

322

1765

1.57

12.83

1.3

77.70

59.85

u/ml

0.45

109

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

6.49

12.83

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

111

439

2.17

12.78

1.3

1.2

0.32

0.30

g/l

1.36

367

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

524

3176

1.42

12.73

1.3

174.28

217.72

miu/ml

1.47

125

1383

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1466

10271

1.24

12.59

2.5

2.4

19.46

23.04

au/ml

0.74

1086

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

105

411

2.19

12.41

1.5

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

121

503

2.06

12.28

1.0

1.1

101.09

94.87

1.10

107

389

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1345

9363

1.24

12.26

1.3

51.26

57.40

au/ml

0.42

643

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

191

2.78

12.18

1.1

1.2

—

(3012898) Urea [Moles/volume] in Urine

137

3.12

12.05

1.3

1.5

132.67

172.08

mmol/l

1.20

117

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

203

2.70

11.92

1.1

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

146

656

1.91

11.91

1.1

1618.72

1532.70

miu/ml

0.36

146

656

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.63

11.81

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.98

11.71

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

146

661

1.89

11.66

4.3

3.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

314

2.32

11.55

2.3

7.14

7.52

mmol/l

0.35

202

(44806071) Cardiolipin IgM antibody measurement

166

2.84

11.25

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

274

1497

1.57

11.15

1.5

1.4

0.20

0.34

nmol/l

4.91

189

1077

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

149

2.93

11.06

1.6

2.1

0.78

1.08

mmol/l

0.49

104

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

146

673

1.86

11.06

1.1

—

1.01

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

114

3.23

10.96

1.4

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

495

3054

1.39

10.93

1.3

1.2

40.19

45.15

u/ml

0.29

276

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

14623

129274

0.90

10.91

55.2

17.9

328.26

332.54

g/l

307.65

14509

128493

(3027944) Amphetamines [Presence] in Urine

508

3156

1.38

10.77

4.4

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

288

1612

1.53

10.55

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

177

2.71

10.55

2.9

2.6

0.86

0.52

u/field

1.43

177

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

126

3.06

10.51

1.2

1.1

—

mmol/l

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

142

664

1.83

10.32

3.6

7.2

42.91

5950.92

u/ml

0.65

132

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

185

935

1.70

10.30

1.5

1.3

2.14

1.37

u/ml

0.48

123

535

(3044009) aPTT.lupus sensitive (LA screen)

3.40

10.26

1.2

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

15486

128182

1.10

10.21

51.8

17.1

14.83

13.59

307.65

15385

126170

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

295

2.26

10.10

1.5

1.2

28.11

39.40

2.16

193

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2743

20695

1.15

10.07

1.5

1.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

4.67

10.05

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1075

0.40

10.05

1.5

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

402

2.07

10.02

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

243

1327

1.57

9.96

3.4

2.9

79.25

46.36

mg/l

0.89

183

938

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

137

641

1.83

9.95

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

231

1247

1.59

9.95

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

218

2.47

9.94

1.8

2.2

15.04

17.87

umol/l

1.16

218

(3012516) Albumin [Mass/volume] in Urine

7126

56905

1.10

9.92

3.6

3.4

74.13

42.51

mg/l

14.77

4951

35422

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

257

2.33

9.72

1.9

2.6

91.81

120.82

au/ml

0.24

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.99

9.71

1.9

1.2

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

4.68

9.68

1.1

1.0

0.01

0.08

u/ml

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

402

2.05

9.66

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

402

2.05

9.66

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

402

2.05

9.66

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

402

2.05

9.66

1.1

—

(4146454) Self-monitoring of blood glucose

319

1860

1.47

9.65

2.7

—

(3016750) Collection duration of Urine

181

930

1.67

9.52

1.8

2.2

505.51

494.44

min

0.64

117

714

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

539

3453

1.34

9.46

1.1

3.02

3.68

0.90

429

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

5.18

9.41

1.1

0.04

0.03

u/ml

0.29

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

121

2.97

9.39

1.1

1.0

15.43

11.51

iu/ml

0.18

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.51

9.31

1.4

1.2

0.07

g/l

0.21

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

323

2.15

9.27

5.5

1.9

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

312

2.17

9.26

1.1

895.65

998.46

titre

0.30

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

3.91

9.14

1.2

1.4

0.92

1.21

u/field

0.69

(3019832) Treponema pallidum Ab [Presence] in Serum

1098

7730

1.22

9.06

1.7

1.6

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

198

2.46

8.96

4.1

3.4

39.36

42.34

umol/l

0.43

168

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.22

8.95

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

107

480

1.91

8.90

1.5

1.2

27.58

23.42

0.21

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

184

2.51

8.84

1.0

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

285

2.19

8.83

1.1

0.73

0.88

umol/24h

0.26

136

(3017509) Phencyclidine [Presence] in Urine

3.38

8.82

2.1

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

258

2.26

8.80

1.2

1.3

87.17

55.72

mu/l

0.61

189

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

5.08

8.75

1.3

1.5

151.80

93.28

ug/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

401

1.99

8.69

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3997

37362

0.90

8.68

3.4

3.3

1.06

0.80

ug/l

9.19

2804

25324

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

582

0.26

8.50

1.3

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

4.19

8.49

1.1

1.0

0.04

0.06

u/ml

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

106

483

1.88

8.44

1.7

1.3

3.05

3.92

umol/l

1.92

428

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

518

3376

1.32

8.14

1.1

7.09

7.54

eliau/ml

0.06

427

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

177

2.47

8.07

4.9

6.3

1985.00

5144.75

iu/ml

—

(3028717) Thiamine [Mass/volume] in Blood

169

2.48

7.87

1.2

1.1

66.88

63.14

ug/l

0.49

169

(3036071) Salmonella sp Ab [Titer] in Serum

317

2.05

7.82

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

317

2.05

7.82

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

568

3772

1.29

7.80

5.9

3.0

32.64

28.17

mg/l

2.14

436

2640

(3009992) Blasts/cells in Bone marrow

13.89

7.79

1.7

1.8

23.46

17.25

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

111

2.85

7.76

1.0

—

(3019174) dRVVT (LA screen)

3.04

7.71

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

203

2.32

7.64

1.5

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

8.55

7.62

1.7

1.4

0.71

0.50

u/field

—

(3018333) Ribosomal P Ab [Presence] in Serum

180

980

1.57

7.60

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

292

2.08

7.59

2.5

3.2

7.25

8.37

mg/l

0.85

234

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

188

2.37

7.57

3.5

5.5

80.71

39.62

ug/min

2.40

158

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.88

7.56

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

153

804

1.63

7.49

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

183

1005

1.56

7.46

1.2

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

3.08

7.44

1.2

2.0

167.40

211.13

ng/l

2.95

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

3.28

7.42

1.1

33.35

60.52

u/l

1.68

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.25

7.41

1.5

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

190

1054

1.55

7.41

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

186

1027

1.55

7.41

1.2

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

169

2.43

7.40

1.2

1.5

8.91

108341.08

nmol/l

1.06

144

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.71

7.29

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

189

1053

1.54

7.24

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

192

1077

1.53

7.14

1.2

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

302

2.01

6.98

1.1

1.2

491.39

276.77

pmol/l

0.43

223

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

201

2.26

6.96

1.8

3.0

60.53

71.87

pmol/l

0.37

176

(3051339) Copper [Moles/volume] in Blood

3.48

6.95

1.2

16.26

16.12

umol/l

0.04

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

208

2.22

6.84

1.9

2.7

99.66

39.10

mg/l

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

193

1100

1.50

6.69

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

172

960

1.54

6.58

7.0

7.4

452.44

43.48

ug/l

1.44

127

625

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

962

0.50

6.57

1.6

1.8

—

(3020961) Endomysium IgA Ab [Titer] in Serum

868

6177

1.21

6.52

1.1

266.58

226.84

titre

0.16

193

(4212803) Bone marrow aspirate examination

139

2.46

6.39

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

135

2.47

6.29

1.2

1.3

92.06

96.27

ug/l

0.08

(43055514) Macroprolactin [Presence] in Serum or Plasma

216

2.14

6.27

1.6

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

782

0.46

6.23

1.3

1.5

49.97

62.32

ug/l

1.47

782

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7652

62227

1.08

6.21

7.2

5.6

10.39

2.92

ug/l

15.05

6783

56401

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

102

511

1.71

6.07

2.3

3.3

27.93

28.53

umol/l

0.17

398

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

376

2449

1.32

6.06

1.1

23876.50

656.70

iu/ml

0.49

415

(3018738) Hemoglobin F/Hemoglobin.total in Blood

3.85

6.02

4.7

3.5

23.76

20.91

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

2.96

5.91

1.1

1.4

—

24851.83

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

101

509

1.70

5.90

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

145

2.36

5.87

1.1

1.0

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

100

2.65

5.77

1.2

1.5

13.45

16.08

pmol/l

0.36

(3030940) RBC casts [#/area] in Urine by Computer assisted method

15.39

5.73

1.0

1.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

15.39

5.73

1.0

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

121

2.47

5.69

1.0

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

5.26

5.62

9.5

7.8

43.11

53.60

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

198

2.12

5.59

1.3

1.4

42.58

48.95

mg/l

0.34

166

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

365

1.81

5.57

4.2

1.9

2008.68

1349.90

pmol/l

0.11

(3046861) Legionella sp Ag [Presence] in Urine

2.65

5.57

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

107

2.56

5.57

4.8

2.7

1499.45

22.96

pmol/l

0.53

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.07

5.56

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

119

638

1.60

5.50

1.4

1.2

155.26

159.33

mmol/24h

0.18

119

638

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

118

2.46

5.49

1.1

1.6

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

3.58

5.47

1.0

140.00

195.35

pmol/l

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

3.58

5.47

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

109

2.51

5.38

1.1

1.0

7.00

7.22

u/ml

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

12.82

5.38

1.0

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.93

5.37

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

222

1360

1.40

5.37

5.7

5.8

180.02

81.30

u/ml

1.03

473

(44806420) Estimation of glomerular filtration rate

128

1664

0.66

5.35

2.4

2.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

120

2.42

5.32

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

110

2.49

5.29

5.8

5.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.63

5.28

44.0

11.6

103.41

105.08

g/l

0.30

(1761482) Bacteria [#/volume] in Urine by Culture

677

4812

1.21

5.23

6.0

3.7

—

(3050794) Legionella sp Ab [Presence] in Serum

137

2.31

5.22

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

561

3920

1.23

5.15

1.3

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

3.89

5.10

6.0

5.5

1.62

1.74

g/l

0.10

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

409

1.72

5.04

1.6

2.2

1.03

1.00

ug/l

0.04

393

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.81

5.01

1.1

1.2

2880.31

3549.16

ng/l

0.20

(3008898) HLA-B27 [Presence]

524

3650

1.23

4.97

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.94

4.96

1.2

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

125

697

1.54

4.93

2.1

37.73

110.23

ug/min

1.35

171

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.75

4.91

9.4

7.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

187

2.06

4.83

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

206

1.99

4.73

1.1

1.2

—

(3036005) Urine sediment comments by Light microscopy Narrative

7.77

4.73

1.0

1.2

—

(3033086) Enterovirus Ab [Titer] in Serum

3.66

4.72

1.1

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.85

4.72

1.1

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.90

4.64

3.7

3.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

8.55

4.52

2.0

2.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

307

0.28

4.51

1.3

1.5

—

(3007916) DNA double strand Ab [Titer] in Serum

170

2.06

4.45

1.6

1.2

104.00

189.59

titre

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

2.90

4.43

1.2

1.5

177.87

195.06

ug/g

0.20

(3045683) HLA typing for celiac disease panel - Blood or Tissue

124

708

1.50

4.43

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.81

4.40

9.4

7.9

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

126

2.24

4.39

2.3

2.2

0.67

0.69

ug/l

0.09

126

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.14

4.37

1.0

—

(37019676) Renin [Units/volume] in Plasma --supine

4.43

4.37

1.0

1.1

73.33

14.93

mu/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

381

1.68

4.37

1.9

1.6

10.08

9.06

ug/l

1.01

381

(37208534) Antinuclear antibody arbitrary concentration in serum

435

1.63

4.30

1.1

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.26

4.27

2.6

4.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

320

1.74

4.25

2.1

1.9

8.67

9.58

mg/l

0.69

268

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.18

4.13

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

110

1390

0.67

4.10

1.1

1.0

0.19

0.42

u/ml

0.92

461

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

119

2.23

4.10

1.0

1.1

—

(3018133) Calcium [Moles/volume] in Urine

236

1.85

4.09

1.6

2.88

2.81

mmol/l

0.07

215

(3028468) Fragments [Presence] in Blood by Light microscopy

8.55

4.07

3.1

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

274

1.78

4.05

1.4

1.3

20.57

289.97

titre

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

135

1639

0.70

4.05

1.1

2.25

3.22

u/ml

0.81

793

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

113

647

1.50

4.02

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

277

1846

1.29

3.93

1.3

1.2

—

(3004775) Volume in Urine collected for unspecified duration

214

1379

1.33

3.89

2.0

2.3

771.79

654.04

2.62

133

933

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

286

1917

1.28

3.89

1.1

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

592

0.52

3.88

1.1

1.0

0.28

0.84

u/ml

—

140

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

111

2.23

3.87

1.2

1.0

9.21

11.63

u/l

0.28

111

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.80

3.78

1.2

1.1

219.22

256.08

nmol/l

0.82

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.51

3.77

1.8

1.7

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.63

3.65

6.9

5.8

497.86

407.24

umol/l

0.59

(3010726) Horse dander IgE Ab [Units/volume] in Serum

160

1851

0.74

3.62

1.1

0.58

1.17

u/ml

2.16

915

(3013466) aPTT in Blood by Coagulation assay

2.80

3.57

1.1

39.25

39.19

0.01

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

122

2.10

3.49

1.2

31.90

25.71

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

111

2.16

3.47

1.0

1.1

—

0.44

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

179

2022

0.75

3.45

1.1

0.83

1.00

u/ml

0.29

839

(3033099) Centromere Ab [Titer] in Serum

361

1.61

3.43

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

112

1359

0.70

3.42

1.0

716.36

710.44

ng/l

0.05

927

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

224

2450

0.78

3.39

1.1

2.27

1.69

u/ml

0.37

121

1280

(3009871) Measles virus Ab [Titer] in Serum

519

1.50

3.37

1.6

2381.18

3685.65

titre

1.06

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

4.09

3.32

4.5

4.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

113

1360

0.71

3.31

1.0

35.59

43.62

ng/l

1.92

944

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.47

3.28

1.2

1.4

142.91

34.95

umol/24h

0.46

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

267

1.70

3.28

3.5

3.4

67.64

125.09

ng/l

1.09

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

420

1.55

3.26

15.1

7.6

5.86

5.97

kpa

0.44

372

(3014599) Egg white IgE Ab [Units/volume] in Serum

677

0.59

3.24

1.1

1.0

3.75

0.99

u/ml

0.39

142

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

113

1355

0.71

3.24

1.0

281.38

347.44

ng/l

1.35

953

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.66

3.24

1.0

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.36

3.22

1.3

1.6

24.10

23.52

mmol/l

0.23

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

145

1.95

3.16

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

267

1828

1.25

3.13

1.1

4.10

2.93

0.39

265

(3003888) Timothy IgE Ab [Units/volume] in Serum

190

2092

0.77

3.07

1.1

3.21

3.68

u/ml

0.26

100

1031

(3038071) Oxygen [Partial pressure] in Mixed venous blood

372

1.56

3.07

16.2

7.2

6.75

5.44

kpa

1.97

372

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

948

0.67

3.07

12.6

18.3

1295.85

1429.85

nmol/l

0.89

904

(40758358) Immune stain study

2.48

3.06

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.42

3.03

1.1

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

694

0.61

3.00

1.1

1.0

0.39

1.55

u/ml

1.24

197

(3029075) Extractable nuclear Ab panel - Serum

129

805

1.37

2.99

1.1

—

0.28

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

158

1775

0.76

2.99

1.3

1.2

7.87

7.50

mmol/l

0.88

136

1483

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.27

2.97

1.4

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1111

0.70

2.94

1.3

102.32

171.02

pmol/l

7.65

1111

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

585

1.43

2.93

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

158

1770

0.76

2.93

1.6

1.8

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

4.88

2.92

1.5

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

135

1543

0.75

2.90

1.1

3.69

3.57

u/ml

0.02

674

(3020650) Glucose [Presence] in Urine

477

1.47

2.82

2.4

1.5

0.00

0.04

estimate

2.10

477

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.29

2.75

1.4

1.6

—

(3051101) Glucose [Moles/volume] in Cord blood

396

0.52

2.73

4.6

6.0

11.21

8.32

mmol/l

0.81

396

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

354

3594

0.84

2.71

1.3

1.5

—

(3034614) HLA Ag [Interpretation]

3.56

2.71

1.6

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.85

2.67

1.1

1.4

1.56

1.92

g/l

—

(3024316) Viscosity of Plasma

2.30

2.63

1.3

2.2

2.11

1.70

mpas

—

(3029396) Erythrocyte agglutination [Presence] in Blood

149

1.84

2.63

1.3

2.7

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

220

1.67

2.59

1.3

53.56

48.44

0.24

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.13

2.58

1.3

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

169

1.77

2.57

1.1

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

412

1.47

2.51

1.7

1.9

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.58

2.42

1.0

1.1

0.22

1.10

umol/24h

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

5.13

2.38

1.0

—

(3001556) Androgen free Index in Serum or Plasma

2.44

2.34

1.5

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

150

1.77

2.29

1.7

2.2

—

(40768800) Prostate Pathology biopsy report

568

4297

1.13

2.21

1.1

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.11

2.20

1.3

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

304

2205

1.18

2.12

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

573

1.36

2.10

1.3

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

289

1.51

2.08

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

208

1.60

2.06

1.6

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

138

1.73

1.98

1.0

1.1

1.93

1.78

umol/24h

0.25

138

(3012989) Citrate [Moles/time] in 24 hour Urine

3.32

1.92

1.4

1.6

1.17

2.32

mmol/24h

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

117

777

1.29

1.91

2.1

1.6

3.89

4.11

ug/l

0.05

585

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

121

1.77

1.89

1.4

1.3

0.19

0.24

nmol/l

0.34

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.90

1.89

1.5

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.97

1.88

1.6

2.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

170

1183

1.23

1.87

1.1

1.2

10.06

9.29

mmol/l

1.19

158

1122

(40762887) Creatinine [Moles/volume] in Blood

116

1.77

1.83

1.9

1.3

—

(3022229) Phosphate [Moles/volume] in Urine

2.22

1.82

1.0

1.1

12.31

16.11

mmol/l

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.01

1.77

1.8

1.5

0.33

0.20

u/l

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.01

1.77

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

17855

153861

0.96

1.73

5.7

5.3

6.24

5.97

mmol/l

95.09

16090

140564

(3041184) Isoniazid [Presence] in Urine

2.99

1.73

1.6

2.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

292

2154

1.16

1.72

1.1

14.07

17.05

au/ml

0.24

477

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.88

1.69

1.0

1.1

24.20

36.18

umol/l

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

3.88

1.69

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.53

1.59

1.4

1.1

246.13

281.26

u/ml

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

3.56

1.58

1.0

1.3

—

(3016330) Potassium [Moles/time] in 24 hour Urine

183

1.54

1.55

1.3

—

79.41

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

164

1.56

1.50

4.1

6.5

10.63

8.27

1.23

164

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

2.19

1.50

1.0

0.07

0.31

u/ml

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

2.19

1.50

1.2

1.3

1.78

1.65

mg/l

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.96

1.48

1.4

1.6

551.81

480.01

nmol/l

0.15

(40761995) Spermatozoa Progressive [#/volume] in Semen

165

1.55

1.47

2.1

3.2

33.07

45.04

1.96

165

(3024666) Lithium [Moles/volume] in Serum or Plasma

104

709

1.25

1.45

11.4

13.6

0.60

0.64

mmol/l

1.20

652

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.85

1.44

2.1

1.4

532.81

310.91

umol/24h

1.18

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.05

1.38

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.05

1.38

2.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.05

1.38

1.0

1.1

0.60

2.07

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.05

1.38

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.05

1.38

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.05

1.38

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.05

1.38

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

1.95

1.36

1.2

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

281

0.64

1.25

1.3

1.2

57.73

71.48

u/ml

0.48

274

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.44

1.25

1.0

1.1

1913.33

2565.24

titre

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.44

1.25

1.0

2.5

0.63

1.85

mu/l

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

434

3375

1.10

1.18

2.2

1.8

187.26

203.31

pmol/l

1.74

412

3207

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

852

6814

1.07

1.18

1.1

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.39

1.13

1.6

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.69

1.12

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

164

1208

1.16

1.10

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

165

0.57

1.06

1.2

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.92

1.02

1.0

1.1

0.01

0.38

u/ml

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.88

1.00

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.57

0.98

1.2

1.1

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.97

0.0

2.9

—

28.43

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.81

0.96

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

121

882

1.17

0.96

1.1

9.13

8.76

iu/ml

0.05

213

(3006969) Lambda light chains [Mass/volume] in Urine

1.86

0.95

1.0

1.2

0.05

0.11

g/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.77

0.92

1.0

1.2

—

(3001729) Color of Synovial fluid

128

1.47

0.91

1.3

1.6

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.95

0.90

1.4

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

116

1.47

0.85

2.4

2.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

847

6864

1.06

0.85

1.1

1.41

4.58

u/ml

0.59

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5758

50057

0.98

0.81

5.2

4.6

22.02

22.08

0.10

2976

26226

(3025018) Bordetella pertussis Ab [Titer] in Serum

111

820

1.16

0.78

1.3

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

595

0.82

0.78

1.7

2.7

150.02

149.87

nmol/l

0.00

530

(3032868) Hemoglobin electrophoresis panel in Blood

112

1.45

0.76

1.6

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

217

1.30

0.72

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

143

1.37

0.71

1.1

0.04

0.50

u/ml

1.40

(3006567) Chloride [Moles/time] in 24 hour Urine

1.94

0.71

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.54

0.69

1.1

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

108

1.42

0.68

1.6

1.4

42.60

42.75

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

131

1.37

0.65

1.2

1.1

6.63

6.15

mmol/l

1.20

131

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

987

8103

1.04

0.64

1.9

1.8

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.71

0.63

2.0

1.6

172.00

363.40

mg/24h

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.63

0.62

1.0

1.1

—

mmol/l

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.61

0.0

1.0

—

0.35

—

(3041806) Other cells [#/volume] in Blood by Manual count

169

0.71

0.59

1.8

1.5

0.51

0.48

e9/l

0.15

169

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

11.88

—

(3005011) Chlamydia sp Ab [Titer] in Serum

149

1.32

0.58

1.5

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

216

0.75

0.56

1.1

25.73

35.67

iu/ml

0.55

216

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.60

0.55

1.2

35.60

33.93

mg/24h

—

(3003740) Influenza virus B Ag [Presence] in Specimen

247

1960

1.08

0.55

1.3

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

106

1.37

0.54

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

888

0.88

0.54

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.44

0.54

1.0

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.48

0.54

1.1

1.0

5.52

0.47

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

246

1958

1.07

0.51

1.3

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

168

1.27

0.50

1.0

1.1

98.36

82.35

ug/l

0.77

118

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

1.38

0.50

1.5

1.4

8.50

11.78

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

1.41

0.48

1.5

1.3

0.63

1.33

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

508

4539

0.96

0.46

2.1

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

419

3761

0.95

0.46

1.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.59

0.46

1.6

1.2

77.80

71.81

ug/l

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.35

0.45

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

538

4406

1.04

0.45

2.1

1.8

40.79

44.20

nmol/l

2.78

515

4296

(3012494) Peanut IgE Ab [Units/volume] in Serum

299

0.83

0.42

1.1

0.41

1.04

u/ml

1.03

142

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.2

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.65

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

128

0.73

0.40

1.0

5.40

14.12

u/ml

0.62

128

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1073

8936

1.03

0.37

1.9

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

192

0.80

0.37

1.1

1.0

2.71

1.90

u/ml

0.13

164

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

1.47

0.36

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

101

1.27

0.32

1.3

1.1

104.53

93.47

titre

0.39

101

(4038314) Semen analysis, post vasectomy

1.28

0.32

1.2

1.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.34

0.30

1.0

1.1

29.64

17.26

u/ml

—

(4133840) Spirometry

368

0.88

0.29

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.20

0.26

1.3

1.2

—

15.95

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.20

0.26

1.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.29

0.23

1.6

1.0

2.20

2.91

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.22

0.22

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

63.45

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1253

10559

1.01

0.19

1.2

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

101

1.18

0.18

1.1

0.15

0.83

u/ml

—

(3045462) Protein/Creatinine [Ratio] in Urine

134

1.15

0.17

3.4

50.08

40.64

mg/mmol

0.22

118

(3041672) Baker's yeast Ab [Presence] in Serum

1.18

0.16

1.0

1.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.16

0.16

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

112

1.14

0.14

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

319

1.07

0.13

6.3

6.7

10.05

10.76

0.90

319

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

203

1689

1.03

0.13

1.1

3.80

4.05

eliau/ml

0.10

774

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

153

0.89

0.12

1.1

1.0

0.03

0.78

u/ml

—

101

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

107

883

1.04

0.11

1.3

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

354

0.94

0.11

1.1

1.0

3.54

9.71

u/ml

3.08

229

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

502

0.95

0.10

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.87

0.10

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

795

0.97

0.09

1.1

20.15

20.74

u/ml

0.05

300

(44813793) Dust mix specific IgE antibody measurement

113

972

0.99

0.01

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

195

1.01

0.00

1.0

—

(3000285) Sodium [Moles/volume] in Blood

379

0.99

0.00

1.3

1.2

137.26

138.23

mmol/l

0.72

328

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

539

1.00

0.00

1.1

17.25

10.33

mm/h

2.43

539

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

593

0.99

0.00

1.1

9.13

8.05

u/ml

0.08

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.92

0.00

1.0

1.2

1.41

1.34

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.2

—

74.84

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.8

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

30.83

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.3

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.93

-0.00

1.0

0.02

0.18

u/ml

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_OXYCODONE – Oxycodone

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Oxycodone

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Case counts by code for Oxycodone (RX_OXYCODONE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints